Benign neoplasm: Colon

CD2_BENIGN_COLON

colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_CAECUM CD2_BENIGN_APPENDIX CD2_BENIGN_ASCENDING_COLON CD2_BENIGN_TRANSVERSE_COLON CD2_BENIGN_DESCENDING_COLON CD2_BENIGN_SIGMOID_COLON CD2_BENIGN_COLON_NOS	27244
6. Filter based on genotype QC (FinnGen only)	26439

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_CAECUM\|CD2_BENIGN_APPENDIX\|CD2_BENIGN_ASCENDING_COLON\|CD2_BENIGN_TRANSVERSE_COLON\|CD2_BENIGN_DESCENDING_COLON\|CD2_BENIGN_SIGMOID_COLON\|CD2_BENIGN_COLON_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	132400	65346	66373
Only index persons	122287	61626	60661
Unadjusted period prevalence (%)
Whole population	1.86	1.87	1.85
Only index persons	2.29	2.27	2.32
Median age at first event (years)
Whole population	66.72	66.73	66.70
Only index persons	66.32	66.30	66.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	26439	12943	13496
Unadjusted period prevalence (%)	5.40	4.59	6.18
Median age at first event (years)	66.43	65.29	67.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
27244: Matched controls
260040

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02BE01

ATC

paracetamol; systemic, rectal

2.1

319.7

24346

207336

B01AB05

ATC

enoxaparin; parenteral

1.7

315.9

9332

61871

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

312.1

3271

15676

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

16.6

307.7

439

256

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.7

307.7

890

1295

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

307.7

4052

18156

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.1

307.7

3058

10102

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

7.5

307.7

606

783

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

10576

71755

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.8

307.7

3448

3782

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

10744

61629

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.2

307.7

810

1100

K63.5

ICD-10 Finland

Polyp of colon

5.2

307.7

1022

1944

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

307.7

12258

52958

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

479.5

307.7

11182

377

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

133.0

307.7

5740

521

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

13.9

307.7

318

221

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

6749

38492

UJH02

NOMESCO Finland

Anoscopy

3.1

307.7

1484

4740

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.9

307.7

10745

30479

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

42.8

307.7

415

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

307.7

3867

17313

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

19498

148922

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

12.5

307.7

404

314

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

3245

15229

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

9.5

307.7

712

732

K92.1

ICD-10 Finland

Melaena

2.9

307.7

2043

7184

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

631.3

307.7

392

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

121.0

307.7

2719

238

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.1

307.7

2163

6967

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

182.1

307.7

8187

612

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

4.7

307.7

4653

11026

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

21.3

307.7

1980

954

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

307.7

2815

11410

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

110.0

307.7

240

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

9032

46651

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.2

307.7

2368

7490

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

148.0

307.7

4234

323

UJF30

NOMESCO Finland

Ileoscopy through colon

6.5

307.7

6612

12164

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

5624

30946

JFA42

NOMESCO Finland

Endoscopic injection in colon

47.3

307.7

463

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

14187

96986

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

129.4

307.7

4299

376

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

307.7

2969

10592

UJF32

NOMESCO Finland

Coloscopy

13.4

307.7

19501

41159

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

51.3

307.7

9655

2754

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

292.5

3517

17710

WX002

NOMESCO Finland

Sedation and analgesia

1.8

286.8

5767

34259

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

286.8

3931

20712

A02BC05

ATC

esomeprazole; systemic

1.6

285.9

11211

79180

K64.0

ICD-10 Finland

First degree haemorrhoids

4.1

279.1

804

1926

Z2221

NOMESCO Finland

Medical doctor

1.7

274.1

7235

46226

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

268.5

6274

38773

J01DB01

ATC

cefalexin; oral

1.7

266.4

21883

182681

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.5

264.0

388

501

K62.1

ICD-10 Finland

Rectal polyp

5.8

260.6

492

826

N02AX02

ATC

tramadol; systemic, rectal

1.6

259.4

12009

87474

R06.0

ICD-10 Finland

Dyspnoea

1.6

254.5

7558

49580

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

253.0

741

1796

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.6

246.2

1541

5885

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

245.6

8004

53608

A02BC03

ATC

lansoprazole; oral

1.6

240.6

8046

54167

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.5

239.7

872

2453

C03CA01

ATC

furosemide; systemic

1.6

231.0

9039

62946

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.4

229.2

596

1320

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

226.6

4562

26894

H02AB06

ATC

prednisolone; systemic

1.5

224.6

12794

96357

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.5

224.2

329

424

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

223.6

1151

3973

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.4

222.5

271

277

D01

ICPC

Abdominal pain/cramps general

1.9

217.3

2862

14782

J01MA02

ATC

ciprofloxacin; systemic

1.5

212.9

10728

78488

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

210.7

6941

46281

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.9

210.6

1012

3363

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

210.2

2597

13113

JN4AD

NOMESCO Finland

Body CT examination

1.9

209.2

3141

16925

R03AC02

ATC

salbutamol; inhalant

1.5

208.4

13624

104879

S18

ICPC

Laceration/cut

1.5

206.4

12423

94012

A07EC02

ATC

mesalazine; oral, rectal

2.4

204.5

1463

5939

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.7

203.4

484

998

JFB30

NOMESCO Finland

Right hemicolectomy

4.1

202.4

567

1329

C05AA08

ATC

fluocortolone; rectal, topical

1.8

202.1

3801

21910

N03AX16

ATC

[U] pregabalin

1.6

202.1

6344

41760

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

201.5

1498

6186

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

9.3

197.1

242

250

AA1AD

NOMESCO Finland

CT of head and brain

1.5

195.8

7707

53303

R4110

NOMESCO Finland

Physiotherapy

1.5

193.9

7365

50523

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

190.6

10551

78135

C07AB07

ATC

bisoprolol; oral

1.5

189.3

13865

108261

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.2

181.9

318

495

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

180.5

9090

65883

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.0

180.4

849

2786

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

180.0

1617

7229

JN4BD

NOMESCO Finland

Extensive body CT

1.8

179.8

3095

17341

M79.6

ICD-10 Finland

Pain in limb

1.5

179.6

10453

77885

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

175.4

1985

9690

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

173.8

1106

4246

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

173.3

4813

30621

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.5

170.8

1132

4429

G47.3

ICD-10 Finland

Sleep apnoea

1.5

170.2

5877

39292

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

168.1

11372

86789

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

168.0

9846

73191

UKC02

NOMESCO Finland

Cystoscopy

1.6

166.6

4695

29942

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

166.4

17270

142158

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

165.6

4725

30217

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

165.3

17384

143349

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

163.6

6820

47392

A06AD11

ATC

lactulose; oral

1.6

163.1

4097

25391

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

31.0

163.0

110

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

163.0

3213

18682

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

161.4

4021

24863

D16

ICPC

Rectal bleeding

3.0

161.3

735

2368

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.8

159.7

299

498

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.1

159.4

444

1036

M54.5

ICD-10 Finland

Low back pain

1.4

159.1

8531

62204

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

155.7

6761

47285

N06AX11

ATC

mirtazapine; oral

1.4

155.5

8367

60989

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

154.1

3349

19972

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.6

152.6

908

3371

A02BC01

ATC

omeprazole; systemic

1.5

151.8

7149

50755

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

151.4

2602

14528

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

151.0

2609

14590

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

17.1

149.9

127

R03BB04

ATC

tiotropium bromide; inhalant

1.7

149.4

2925

16947

R53

ICD-10 Finland

Malaise and fatigue

1.5

149.1

5786

39493

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

149.0

1472

6820

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

148.7

1065

4316

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.0

147.9

696

2283

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

147.7

3956

24849

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

147.2

9988

75707

Z3231

NOMESCO Finland

Registered nurse

1.5

146.6

6996

49729

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

146.4

2824

16289

UJG02

NOMESCO Finland

Proctoscopy

2.9

145.9

706

2352

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.8

145.4

448

1125

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

143.6

9028

67445

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

143.4

6630

46804

J01CA04

ATC

amoxicillin; systemic

1.4

142.6

20189

172877

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

142.4

6324

44287

J01AA02

ATC

doxycycline; systemic

1.4

142.4

20205

173059

K51.5

ICD-10 Finland

Left sided colitis

2.9

140.8

690

2314

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

137.5

4805

32006

Z3226

NOMESCO Finland

Physiotherapist

1.5

137.2

4589

30277

A07EA06

ATC

budesonide; oral, local oral

2.4

135.9

942

3759

SPAT1263

SPAT

Sampling

1.4

135.8

10286

79109

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

135.5

4877

32676

A10BA02

ATC

metformin; oral

1.4

135.5

7715

56497

K30

ICD-10 Finland

Functional dyspepsia

1.7

135.2

2721

15859

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

134.1

6912

49693

C08CA01

ATC

amlodipine; oral

1.4

131.9

10667

82800

C10AA05

ATC

atorvastatin; oral

1.4

131.8

11697

92152

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

131.7

4183

27259

K59.0

ICD-10 Finland

Constipation

2.0

130.8

1534

7561

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

129.9

12240

97265

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

129.9

3560

22424

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

129.8

4829

32545

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.5

128.9

835

3228

J01MA12

ATC

levofloxacin; systemic

1.5

128.2

4926

33408

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

128.0

949

3902

A02BA02

ATC

ranitidine; systemic

1.5

128.0

5072

34613

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.6

126.7

765

2859

L17

ICPC

Foot/toe symptom/complaint

1.4

126.3

7152

52185

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

126.3

828

3219

G04CA02

ATC

tamsulosin; oral

1.4

125.7

6762

48887

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

125.6

4814

32615

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

125.4

3931

25516

H02AB07

ATC

prednisone; oral

1.6

124.3

3529

22393

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

123.1

7232

53061

R42

ICD-10 Finland

Dizziness and giddiness

1.4

122.8

5925

41958

T90

ICPC

Diabetes non-insulin dependent

1.4

122.1

6527

47085

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

120.8

3734

24144

B01AA03

ATC

warfarin; systemic

1.5

120.4

5326

37086

UJF30, ,

SPAT

4.3

120.0

312

691

R51.80

ICD-10 Finland

Headache

1.6

119.2

3221

20190

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

119.1

2551

15091

WX402

NOMESCO Finland

General anaesthesia

1.5

118.9

4975

34257

XKD00

NOMESCO Finland

Uroflowmetry

1.5

118.7

4494

30329

D06

ICPC

Abdominal pain localized other

1.8

118.7

2003

11090

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.1

118.2

334

788

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

118.0

1798

9652

D11

ICPC

Diarrhoea

1.7

117.6

2380

13865

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

116.6

4972

34347

N05CF01

ATC

zopiclone; oral

1.4

115.5

8279

62656

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

115.1

8993

68983

ZXA00

NOMESCO Finland

Right side

1.4

115.1

6889

50594

E0000UV, ,

ATC

1.4

114.4

9825

76459

L03

ICPC

Low back symptom/complaint

1.4

114.3

6351

46035

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

113.8

4246

28546

207

Kela drug reimbursment

Chronic arrhythmias

1.5

113.6

4478

30438

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.0

113.3

519

1676

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

113.3

6303

45688

M25.5

ICD-10 Finland

Pain in joint

1.4

112.0

7196

53435

XF402

NOMESCO Finland

ECG with work load test

1.6

111.9

2896

17947

ZX120

NOMESCO Finland

Intravenous

1.7

111.9

2402

14205

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.9

111.2

334

824

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

3.8

109.5

337

846

A06AC51

ATC

ispaghula, combinations; oral

2.0

108.9

1262

6187

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

108.0

2680

16433

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

107.9

1055

4858

N03AX12

ATC

[U] gabapentin; oral

1.5

107.9

4043

27173

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

107.8

2891

18060

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.2

107.7

292

668

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

107.5

6406

46911

WX892

NOMESCO Finland

Monitored bed care

1.7

106.8

1990

11321

A98

ICPC

Health maint/preventive medicine

1.7

106.8

25271

229677

J01FA06

ATC

roxithromycin; oral

1.3

106.5

9568

74736

R02

ICPC

Shortness of breath/dyspnoea

1.5

105.4

3278

21174

UJF34

NOMESCO Finland

Left colonoscopy

4.4

105.0

270

593

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

104.8

4087

27675

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

104.5

12854

104942

R01AD09

ATC

mometasone; nasal

1.3

104.4

10098

79667

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

104.4

16614

140628

A10BH01

ATC

sitagliptin; oral

1.6

103.8

2584

15848

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

103.2

10855

86633

M04AA01

ATC

allopurinol; systemic

1.5

103.1

3598

23812

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

101.7

638

2428

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

101.6

1711

9453

C10AA01

ATC

simvastatin; oral

1.3

101.3

11899

96359

A04

ICPC

Weakness/tiredness general

1.5

101.0

3376

22131

J01DA01

ATC

[U] cefalexin

1.3

100.2

15023

125732

C10AC01

ATC

colestyramine; oral

2.4

100.0

720

2920

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.4

99.9

200

355

UJD02

NOMESCO Finland

Gastroscopy

1.9

99.8

1262

6371

R03BA02

ATC

budesonide; inhalant

1.5

99.7

4059

27694

ZXA05

NOMESCO Finland

Left side

1.4

99.3

6360

47027

ZXD05

NOMESCO Finland

Urgent procedure

1.4

98.9

7041

52942

R07.3

ICD-10 Finland

Other chest pain

1.6

98.8

2516

15507

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

98.6

4138

28389

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.5

98.3

194

340

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

10.5

98.2

110

100

R60.0

ICD-10 Finland

Localized oedema

1.5

98.0

3181

20715

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

97.2

4035

27617

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

97.2

6065

44625

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

96.7

6462

48069

SPAT1153

SPAT

Removal of sutures

1.3

96.4

8115

62537

L04AX01

ATC

azathioprine; systemic

2.1

96.4

1001

4714

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.4

96.2

670

2677

I84

ICD-10 Finland

Hemorrhoids

2.4

95.8

715

2947

G44.2

ICD-10 Finland

Tension-type headache

1.5

94.9

2862

18329

R52.9

ICD-10 Finland

Pain, unspecified

1.6

94.6

2311

14092

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

94.5

1728

9769

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

94.0

2918

18808

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

3.9

93.9

279

683

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

18.4

93.9

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

92.6

814

3593

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

92.2

1739

9915

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

92.0

1587

8822

SFA10

NOMESCO Finland

One-surface restoration

1.3

91.9

12334

101199

C01DA14

ATC

isosorbide mononitrate; oral

1.4

91.5

4227

29484

SPAT1104

SPAT

Monitoring of emergency patient

1.7

91.0

1660

9375

J01FF01

ATC

clindamycin; systemic

1.4

90.8

6475

48573

J02AC01

ATC

fluconazole; systemic

1.3

90.8

8385

65354

R19.4

ICD-10 Finland

Change in bowel habit

2.3

90.7

721

3053

M48.0

ICD-10 Finland

Spinal stenosis

1.5

90.2

3344

22355

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

90.1

2637

16764

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

89.8

618

2456

M03BX02

ATC

tizanidine; oral

1.3

89.5

14576

122457

C03DA01

ATC

spironolactone; oral

1.5

89.5

3150

20837

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

89.4

3472

23426

K57

ICD-10 Finland

Diverticular disease of intestine

2.5

89.4

591

2306

B01AF02

ATC

apixaban; oral

1.5

88.9

3464

23381

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

88.9

414

1350

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

88.7

1147

5831

C187, 8211, 2

ICD-O-3

23.9

88.2

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

87.8

5127

37219

H02AB04

ATC

methylprednisolone; systemic

1.5

87.4

3445

23301

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

87.0

3348

22537

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

87.0

4311

30425

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

86.9

8611

67674

B80

ICPC

Iron deficiency anaemia

2.5

86.8

579

2268

L01BC06

ATC

capecitabine; oral

2.0

86.7

1041

5160

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

86.7

1145

5861

R50.9

ICD-10 Finland

Fever, unspecified

1.5

86.2

3411

23086

D12

ICPC

Constipation

2.0

85.4

929

4448

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

84.8

7688

59628

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

84.7

9117

72394

J45

ICD-10 Finland

Asthma

1.6

84.3

2257

14051

D18

ICPC

Change in faeces/bowel movements

2.4

84.2

622

2551

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

84.0

635

2631

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

83.6

2879

18941

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

83.5

1801

10633

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

82.9

1686

9800

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.1

82.9

354

1098

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

82.4

1481

8323

Z01.7

ICD-10 Finland

Laboratory examination

1.5

82.3

3247

21947

N06AX21

ATC

duloxetine; oral

1.5

82.1

2541

16339

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

81.7

10437

84628

R13

ICD-10 Finland

Dysphagia

1.7

81.7

1703

9965

B82

ICPC

Anaemia other/unspecified

2.2

81.0

723

3211

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

4.1

81.0

227

533

A02BC04

ATC

rabeprazole; oral

1.6

80.7

1948

11825

K02.1

ICD-10 Finland

Caries of dentine

1.3

80.0

12889

107469

R31

ICD-10 Finland

Unspecified haematuria

1.5

79.7

2688

17595

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.7

79.7

434

1540

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

79.6

435

1546

N06AB04

ATC

citalopram; systemic

1.4

79.6

4734

34400

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

79.4

4149

29503

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

79.3

5923

44591

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

78.6

3312

22654

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

78.6

1542

8876

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

78.5

1786

10684

XF404

NOMESCO Finland

Ambulatory ECG

1.6

78.4

2212

13927

N05BA04

ATC

oxazepam; oral

1.3

78.2

5899

44460

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

77.9

5172

38226

A07EA02

ATC

hydrocortisone; rectal

2.4

77.7

527

2080

R03AC03

ATC

terbutaline; inhalant

1.5

77.7

3033

20440

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.6

77.6

188

394

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

77.5

1186

6356

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

77.5

2406

15468

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

77.4

1833

11074

R05

ICD-10 Finland

Cough

1.4

76.7

4900

35987

K64.8

ICD-10 Finland

Other specified haemorrhoids

3.7

76.5

245

633

D64.8

ICD-10 Finland

Other specified anaemias

2.5

76.4

500

1941

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

76.1

14632

124301

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

6.8

76.1

121

171

M79.1

ICD-10 Finland

Myalgia

1.5

76.0

2968

19999

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.1

75.9

162

305

SPAT1301

SPAT

No procedures

1.3

75.9

7563

59227

WX722

NOMESCO Finland

PEEP

1.8

75.9

1170

6286

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

75.8

2623

17250

R35

ICD-10 Finland

Polyuria

1.6

75.7

1718

10267

A10AE04

ATC

insulin glargine; parenteral

1.5

75.2

2316

14859

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

74.9

1948

12032

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

74.6

2339

15066

3AC01, ,

NOMESCO Finland

3.4

74.5

278

795

A01

ICPC

Pain general/multiple sites

1.6

74.2

2108

13285

R06AE07

ATC

cetirizine; oral

1.3

73.5

9623

77949

JFB43

NOMESCO Finland

Left hemicolectomy

4.0

73.2

210

502

A07AA02

ATC

nystatin; oral

1.7

73.2

1456

8409

R03DC03

ATC

montelukast; oral

1.4

73.1

3432

23921

N06AX16

ATC

venlafaxine; oral

1.5

72.9

2752

18410

Z01.2

ICD-10 Finland

Dental examination

1.3

72.7

9738

79072

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

72.5

763

3609

M10.9

ICD-10 Finland

Gout, unspecified

1.6

72.2

1804

11033

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

72.0

4194

30314

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

72.0

967

4975

R11

ICD-10 Finland

Nausea and vomiting

1.6

71.8

1843

11344

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

71.8

9047

72883

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

71.6

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

71.6

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.4

71.5

501

2008

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

4.4

70.9

178

384

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

70.9

1946

12165

R96

ICPC

Asthma

1.5

70.9

2186

14023

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

70.9

4585

33689

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

70.8

1864

11539

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.4

70.8

265

759

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

70.8

1344

7662

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

70.8

8157

64952

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

70.7

5981

45714

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

3.9

70.2

209

513

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

70.2

4390

32083

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.0

70.0

767

3680

JF2BD

NOMESCO Finland

Extensive colon CT

3.2

70.0

279

831

Z71.8

ICD-10 Finland

Other specified counselling

1.3

69.7

6581

51041

K78

ICPC

Atrial fibrillation/flutter

1.5

69.7

2063

13113

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

3.8

69.7

217

550

WX290

NOMESCO Finland

Other blockage of nerve

1.3

69.7

9175

74235

R01AD08

ATC

fluticasone; nasal

1.3

69.3

6055

46468

A10BH05

ATC

linagliptin; oral

1.7

69.2

1354

7781

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

69.1

2962

20290

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

68.7

6903

53962

D07AC01

ATC

betamethasone; topical

1.3

68.4

8498

68231

J20

ICD-10 Finland

Acute bronchitis

1.5

68.3

2230

14475

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

68.2

1688

10296

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

68.2

4378

32106

A11

ICPC

Chest pain NOS

1.5

67.7

1982

12565

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

67.4

2240

14591

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

67.4

8969

72581

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

67.1

4382

32211

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

66.7

2233

14567

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.1

66.5

658

3041

G04BD12

ATC

mirabegron; oral

1.4

66.4

3005

20780

S29

ICPC

Skin symptom/complaint other

1.4

66.1

4442

32787

JAH01

NOMESCO Finland

Laparoscopy

1.9

66.1

917

4765

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

66.1

827

4155

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

65.7

1264

7230

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

65.7

5949

45823

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

65.7

2496

16702

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

65.6

4547

33716

SPAT1254

SPAT

Administration of medicine

1.4

65.6

3440

24404

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

65.5

1465

8715

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

65.4

1243

7086

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

65.2

1424

8419

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

65.2

3311

23355

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.3

65.2

170

378

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

65.1

2492

16694

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

65.1

2878

19813

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

64.9

1168

6558

A28

ICPC

Limited function/disability NOS

1.4

64.9

4323

31860

1381

FHL

Colonoscopy and polyp removal

36.5

64.8

WX320

NOMESCO Finland

Spinalanesthesy

1.3

64.6

5824

44814

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

64.2

966

5148

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

64.2

4645

34650

K51.8

ICD-10 Finland

Other ulcerative colitis

2.9

64.1

315

1059

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.3

64.1

516

2197

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

64.0

2496

16779

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

64.0

1891

12007

C189, 8211, 2

ICD-O-3

26.9

63.5

B01AC04

ATC

clopidogrel; oral

1.3

63.4

4311

31852

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

63.4

1690

10484

G04CB01

ATC

finasteride; oral

1.4

63.3

2931

20337

J01FA10

ATC

azithromycin; systemic

1.2

63.2

12386

104484

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

63.1

3802

27574

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

63.0

3941

28749

C09CA06

ATC

candesartan; oral

1.3

63.0

5535

42420

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

63.0

2213

14573

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

62.9

1338

7857

R03BA05

ATC

fluticasone; inhalant

1.4

62.8

3861

28087

SPAT1262

SPAT

Handing over of treatment supplies

1.3

62.4

4337

32145

N05CF02

ATC

zolpidem; oral

1.4

62.3

3751

27192

SFA20

NOMESCO Finland

Two-surface restoration

1.2

62.2

12806

108527

M02AA07

ATC

piroxicam; topical

1.3

62.2

8799

71537

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

4.5

62.2

154

329

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

62.1

2619

17864

D02

ICPC

Abdominal pain epigastric

1.7

62.1

1275

7420

SPAT1097

SPAT

Recording of ECG

1.4

61.9

3659

26445

B01AB10

ATC

tinzaparin; parenteral

1.5

61.9

2351

15718

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

61.9

3009

21053

N17

ICPC

Vertigo/dizziness

1.4

61.9

2819

19500

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

61.7

15490

134047

E66.8

ICD-10 Finland

Other obesity

1.8

61.7

1010

5520

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

61.5

5895

45683

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

61.5

2316

15460

-, ,

ICD-10 Finland

2.1

61.2

568

2561

M01AH05

ATC

etoricoxib; oral

1.2

61.2

14425

123935

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.7

61.1

324

1135

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

61.0

1784

11298

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.3

60.9

159

354

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

60.9

1184

6790

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

60.7

2548

17361

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

60.6

565

2553

R15

ICD-10 Finland

Faecal incontinence

2.0

60.5

688

3346

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

60.3

841

4378

ZXE00

NOMESCO Finland

One hour or less

1.3

60.2

8900

72648

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

60.1

6537

51451

A03FA02

ATC

cisapride; oral, rectal

1.5

60.1

1776

11275

A10AB05

ATC

insulin aspart; parenteral

1.6

60.0

1713

10789

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.6

59.8

115

197

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

59.6

1118

6348

C09CA01

ATC

losartan; oral

1.3

59.6

6461

50821

-60

ICPC

Result test/procedure

1.6

59.5

1321

7840

B01AF01

ATC

rivaroxaban; oral

1.4

59.5

3223

22957

J01FA09

ATC

clarithromycin; systemic

1.3

59.5

6712

53058

G04CA01

ATC

alfuzosin; oral

1.4

59.5

3165

22478

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

6.5

59.5

144

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

59.0

1028

5718

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

59.0

560

2548

JFA05

NOMESCO Finland

Endoscopic polypectomy in small intestine

13.7

58.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

58.7

3151

22404

205

Kela drug reimbursment

Chronic hypertension

1.3

58.7

7088

56473

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

58.7

4927

37474

SPAT1312

SPAT

General health counselling

1.3

58.7

6934

55106

JFA15, ,

SPAT

3.4

58.6

214

604

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

58.5

1764

11244

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

58.5

1741

11068

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

58.4

1414

8573

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

58.3

3483

25197

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

58.2

1677

10585

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

58.1

9753

80647

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

58.1

359

1358

N06AB10

ATC

escitalopram; oral

1.4

57.9

3753

27493

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.6

57.8

329

1195

L01

ICPC

Neck symptom/complaint

1.4

57.7

3178

22689

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.0

57.1

252

798

M54

ICD-10 Finland

Dorsalgia

1.4

57.0

2381

16197

K29.8

ICD-10 Finland

Duodenitis

3.0

57.0

251

794

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

57.0

6875

54735

SFA30

NOMESCO Finland

Three-surface restoration

1.2

56.8

9532

78767

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

56.5

5316

41021

N30.0

ICD-10 Finland

Acute cystitis

1.4

56.3

3444

24994

J01EA01

ATC

trimethoprim; systemic

1.3

56.3

5730

44664

JG1CG

NOMESCO Finland

Extensive MRI of rectum

3.6

56.2

186

492

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

56.0

954

5272

J01MA14

ATC

moxifloxacin; systemic

1.5

55.9

2042

13538

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

55.9

2047

13579

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

55.8

1248

7420

R01AD58

ATC

fluticasone, combinations; nasal

1.3

55.8

4435

33453

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

55.5

2632

18317

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

2.9

55.1

266

886

K62.0

ICD-10 Finland

Anal polyp

2.9

55.0

258

846

130

Kela drug reimbursment

Malignant tumour

1.5

54.9

2184

14716

R19.5

ICD-10 Finland

Other faecal abnormalities

2.4

54.9

385

1545

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

54.7

2086

13943

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

6.7

54.7

126

M01AE02

ATC

naproxen; oral, rectal

1.2

54.7

12678

108185

C10AX09

ATC

ezetimibe; oral

1.3

54.7

3849

28524

ZXA10

NOMESCO Finland

Bilateral

1.3

54.6

4383

33094

A10BK03

ATC

empagliflozin; oral

1.4

54.5

2276

15475

N02BF02

ATC

pregabalin; oral

1.6

54.5

1240

7402

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.2

54.5

451

1943

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

54.5

3098

22219

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

19.1

54.5

A08

ICPC

Swelling

1.6

54.4

1213

7204

TK800

NOMESCO Finland

Hemodialysis

2.1

54.4

519

2366

A11CC03

ATC

alfacalcidol; systemic

2.0

54.2

566

2669

U07

ICPC

Urine symptom/complaint other

1.5

54.2

1720

11079

A46

ICD-10 Finland

Erysipelas

1.3

54.2

3552

26042

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

4.3

53.8

142

319

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.5

53.8

1643

10497

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

53.4

4081

30592

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

53.3

1424

8831

N01

ICPC

Headache

1.5

53.3

1699

10954

N02BF01

ATC

gabapentin; oral

1.5

53.1

1755

11399

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.8

53.0

270

926

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

52.8

1520

9585

K50.8

ICD-10 Finland

Other Crohn disease

2.7

52.8

298

1078

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

52.8

1841

12090

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

52.8

935

5226

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.2

52.7

463

2044

R03AC13

ATC

formoterol; inhalant

1.7

52.7

1116

6543

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

52.6

1097

6405

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

52.6

845

4592

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

6.1

52.5

144

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.1

52.4

517

2388

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

52.3

4434

33701

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

52.2

1364

8416

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

52.2

L05

ICPC

Flank/axilla symptom/complaint

1.6

52.2

1311

8015

R5110, ,

SPAT

1.5

52.1

1560

9921

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

52.1

6840

54878

C07AA05

ATC

propranolol; systemic

1.3

52.0

3995

29955

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

52.0

1191

7121

N06AA09

ATC

amitriptyline; systemic

1.4

52.0

2220

15153

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

52.0

1478

9295

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

4.8

51.9

119

239

J46

ICD-10 Finland

Status asthmaticus

2.0

51.8

612

3016

K96

ICPC

Haemorrhoids

2.0

51.8

567

2721

SDA03

NOMESCO Finland

Periodontal treatment

1.2

51.7

8382

68816

D50

ICD-10 Finland

Iron deficiency anaemia

2.2

51.5

429

1853

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

51.5

6601

52805

SPAT1325

SPAT

Vaccination

1.2

51.5

8038

65720

EBA00

NOMESCO Finland

Extraction of tooth

1.2

51.4

7607

61830

K22.7

ICD-10 Finland

Barrett oesophagus

2.4

51.3

353

1404

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

51.2

461

2055

L15

ICPC

Knee symptom/complaint

1.3

51.2

5346

41727

R33

ICD-10 Finland

Retention of urine

1.5

51.1

1969

13184

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

51.0

600

2953

SPAT1255

SPAT

Intravenous administration of medicine

1.5

51.0

1568

10031

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

50.9

338

1323

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

50.8

1686

10958

C10AA07

ATC

rosuvastatin; oral

1.2

50.8

7800

63640

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

4.6

50.7

121

251

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

50.7

2502

17515

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

50.7

5950

47096

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

50.6

5313

41494

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

50.5

1648

10675

D78

ICPC

Neoplasm digestive benign/unspecif

6.8

50.4

113

A10BJ06

ATC

semaglutide; parenteral

1.7

50.2

1037

6040

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

50.2

7015

56632

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

50.1

8266

67930

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

50.1

5365

41993

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

50.0

1643

10656

R4190

NOMESCO Finland

Nutritional therapy

1.8

50.0

717

3765

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

49.9

1243

7583

Z2446

NOMESCO Finland

Social worker

1.6

49.9

1234

7516

JEA01

NOMESCO Finland

Laparoscopic appendectomy

1.9

49.8

633

3197

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

49.7

517

2435

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

49.6

765

4108

R05

ICPC

Cough

1.3

49.4

5138

40060

KMAK, ,

NOMESCO Finland

1.2

49.4

10757

90884

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

49.4

1307

8087

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

49.3

1501

9579

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

49.2

881

4937

R03BA01

ATC

beclometasone; inhalant

1.4

49.2

3048

22129

L13

ICPC

Hip symptom/complaint

1.3

49.2

4262

32461

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.0

49.1

549

2654

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

49.0

710

3741

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

48.9

4303

32838

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

48.9

930

5300

I50.0

ICD-10 Finland

Congestive heart failure

1.5

48.8

1825

12143

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

48.7

1020

5961

L08

ICPC

Shoulder symptom/complaint

1.3

48.5

4906

38105

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

48.5

1226

7506

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.3

48.4

392

1675

E000001, ,

ATC

1.3

48.3

4063

30814

U02

ICPC

Urinary frequency/urgency

1.4

48.3

3040

22122

WX882

NOMESCO Finland

High dependency care

1.9

48.3

620

3143

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

48.1

1351

8469

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

48.0

720

3832

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

48.0

751

4049

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

48.0

1388

8760

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

47.9

2225

15410

A10BB12

ATC

glimepiride; oral

1.5

47.8

1660

10887

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

47.6

2927

21220

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

47.5

4311

33015

R74

ICPC

Upper respiratory infection acute

1.3

47.3

5349

42097

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

47.3

784

4300

C09AA05

ATC

ramipril; oral

1.2

47.3

6367

51125

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.0

47.2

519

2494

R03BA08

ATC

ciclesonide; inhalant

1.5

47.2

1766

11750

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

47.1

740

3995

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

73.9

46.9

SPAT1216

SPAT

Assessment of functional ability

1.3

46.9

3768

28393

S97

ICPC

Chronic ulcer skin

1.5

46.7

1442

9229

X58

ICD-10 Finland

Exposure to other specified factors

1.4

46.6

2788

20122

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

46.6

22043

200387

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

46.6

608

3098

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

46.5

2217

15417

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

46.5

2070

14224

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

46.4

9918

83473

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

46.4

1252

7780

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

46.3

4893

38180

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

46.3

1439

9222

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

7250

44827

1.74

318.52

1.8

1124.65

1169.81

nmol/l

3.66

5565

33492

(3024561) Albumin [Mass/volume] in Serum or Plasma

15222

98696

2.07

307.65

6.1

4.7

35.11

35.01

g/l

1.39

14360

91137

(3013115) Eosinophils [#/volume] in Blood

15812

110594

1.87

307.65

7.1

5.9

0.19

0.20

e9/l

1.58

13857

96008

(3044640) Blood type and Crossmatch panel - Blood

10930

69666

1.83

307.65

2.9

2.4

—

(3019198) Lymphocytes [#/volume] in Blood

15659

109646

1.85

307.65

6.9

5.8

1.86

1.90

e9/l

1.25

13846

95985

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25024

212420

2.53

307.65

22.5

15.4

25.43

25.39

mg/l

0.06

21510

170743

(3001604) Monocytes [#/volume] in Blood

15369

106976

1.85

307.65

6.8

5.7

0.60

0.61

e9/l

0.24

13313

91682

(3022217) INR in Platelet poor plasma by Coagulation assay

15400

111189

1.74

307.65

21.1

16.1

1.34

1.31

inr

2.12

3449

32182

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10123

54917

2.21

307.65

2.8

2.2

3.28

3.00

mg/l

20.43

8843

46456

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13311

84260

1.99

307.65

3.8

2.8

132.86

155.18

ug/l

13.71

12332

76763

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14915

104668

1.80

307.65

7.4

6.0

1.21

mmol/l

6.46

13712

94879

(3021960) Folate [Moles/volume] in Serum or Plasma

8585

54001

1.76

307.65

1.7

1.5

20.63

20.34

nmol/l

0.78

7445

45642

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10507

70891

1.67

307.65

3.4

3.0

1657.80

1494.01

ng/l

2.24

9158

61165

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2852

11896

2.44

307.65

2.7

2.4

—

(3006504) Eosinophils/100 leukocytes in Blood

14013

100596

1.68

307.65

7.1

6.0

2.82

2.87

2.03

13059

93576

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6330

32785

2.10

307.65

3.2

2.5

2.35

2.29

g/l

14.85

5916

30126

(3013650) Neutrophils [#/volume] in Blood by Automated count

17333

124281

1.91

307.65

10.0

9.1

4.24

4.19

e9/l

1.79

15169

107931

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5800

24045

2.65

307.65

4.4

4.0

17.07

28.33

ug/l

1.19

4860

19685

(3013826) Glucose [Moles/volume] in Serum or Plasma

17619

132265

1.77

307.65

6.0

4.8

6.89

6.81

mmol/l

4.29

16731

124558

(40768804) Tissue Pathology biopsy report

13454

86935

1.94

307.65

2.5

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14466

101942

1.76

307.65

3.1

2.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6033

30899

2.11

307.65

3.2

2.5

20.68

22.47

18.70

5253

26060

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11292

69893

1.93

307.65

3.0

2.6

61.48

63.69

u/l

0.37

10512

64185

(3013707) Erythrocyte sedimentation rate by Westergren method

20878

160434

2.04

307.65

5.2

4.1

14.18

13.30

mm/h

12.52

19347

147364

(3018010) Neutrophils/100 leukocytes in Blood

14135

101626

1.68

307.65

7.0

5.9

58.44

57.83

7.43

13199

94785

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7367

40226

2.03

307.65

1.3

1.2

1.56

1.73

u/ml

0.46

1741

10467

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17338

116654

2.15

307.65

7.0

6.3

11.37

11.79

umol/l

4.30

16549

110648

(3031040) Bacteria [#/volume] in Urine by Automated count

19005

144652

1.84

307.65

5.7

4.6

376.91

1510.60

e6/l

6.28

162

2296

(3019069) Monocytes/100 leukocytes in Blood

14071

101168

1.68

307.65

7.5

6.3

8.80

8.76

0.98

13136

94228

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14373

94440

1.96

307.65

2.3

2.0

94.77

95.07

pmol/l

0.31

8003

48488

(3007164) IgA [Mass/volume] in Serum or Plasma

6600

35449

2.03

307.65

1.5

2.62

2.58

g/l

0.62

3730

20832

(3006315) Basophils [#/volume] in Blood

15434

107282

1.86

307.65

6.9

5.7

0.04

e9/l

0.20

13352

91907

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8648

53145

1.81

307.65

2.8

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

5310

21341

2.71

307.65

2.4

2.1

148.57

147.65

ug/g

0.06

4245

16622

(3022145) Colonoscopy Study observation

10117

20052

7.07

307.65

1.5

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

22519

170978

2.48

307.65

9.7

7.6

79.93

79.68

u/l

0.30

21502

160519

(40768797) Stomach Pathology biopsy report

6393

29517

2.39

307.65

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

19454

150129

1.83

307.65

5.5

4.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17315

133352

1.66

307.65

4.0

3.1

60.12

53.04

u/l

12.70

16039

122568

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16021

115240

1.79

307.65

8.7

6.7

1.21

mmol/l

11.73

14234

96972

(3022096) Basophils/100 leukocytes in Blood

13620

97599

1.66

307.65

7.2

6.0

0.68

0.67

1.08

12681

90603

(3022948) Iron [Moles/volume] in Serum or Plasma

6752

35328

2.10

307.65

3.2

2.5

11.91

12.73

umol/l

17.51

6356

32655

(3027945) Reticulocytes/100 erythrocytes in Blood

4970

26468

1.97

307.65

2.5

2.4

1.81

1.78

1.30

4384

23289

(3033658) Prothrombin time (PT) actual/Normal

8841

56320

1.74

307.65

5.1

3.9

87.83

88.07

0.36

8662

54935

(40760892) CBC W Ordered Manual Differential panel - Blood

14480

100712

1.79

307.65

7.2

6.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

14275

103317

1.67

307.65

7.3

6.1

26.36

26.99

9.36

13340

96460

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3372

16443

2.09

307.07

1.7

1.6

—

(3023368) Bacteria identified in Blood by Culture

9525

64256

1.64

296.42

4.9

4.3

—

(3015736) pH of Urine

11840

84577

1.59

288.69

4.4

3.5

5.82

5.80

0.19

526

4877

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6398

39239

1.73

283.92

3.2

2.8

1.16

1.22

e6/l

0.26

3910

22518

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12243

88532

1.58

280.55

4.6

3.8

40.55

72.25

ng/l

4.53

9204

64932

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4471

24743

1.87

280.25

3.1

2.7

8.15

9.43

umol/l

3.73

3929

21542

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2403

10631

2.27

278.27

1.7

1.6

1.58

g/l

0.02

2082

8996

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23073

195056

1.84

276.08

5.6

4.7

2.04

2.13

mu/l

0.37

21199

176259

(3011397) Hemoglobin [Presence] in Urine by Test strip

7774

50664

1.65

272.29

4.6

3.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3767

19884

1.94

272.21

2.8

2.5

48.15

47.35

u/l

0.03

3212

16965

(40758558) Short blood count panel - Blood

8268

54732

1.63

272.08

7.5

7.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

25524

224012

2.39

268.35

26.2

18.0

139.62

139.66

mmol/l

1.94

25124

218347

(3023520) Reticulocytes [#/volume] in Blood

3777

20049

1.93

268.08

2.6

69.96

68.93

e9/l

0.99

2903

15278

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12200

88775

1.56

267.57

2.6

2.2

78.26

1123.71

nmol/l

0.50

10809

78487

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3936

21228

1.90

266.05

2.6

2.1

0.22

0.21

g/l

9.58

3692

19601

(3023103) Potassium [Moles/volume] in Serum or Plasma

25536

224527

2.36

260.63

26.4

18.1

3.98

mmol/l

0.05

25107

218512

(3018095) Leukocytes [#/volume] in Urine

11117

79548

1.56

260.21

4.6

3.8

80.24

113.31

e6/l

5.02

8117

57381

(40761511) CBC panel - Blood by Automated count

25064

218808

2.17

259.03

21.5

14.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19671

160304

1.62

256.58

4.4

4.0

14.99

14.94

pmol/l

1.59

17898

143878

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9766

68405

1.57

247.63

3.7

3.2

35.40

35.00

u/l

0.11

9173

64539

(3015377) Calcium [Moles/volume] in Serum or Plasma

10706

76735

1.55

243.82

3.6

3.4

2.35

mmol/l

2.36

9222

66774

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1611

6373

2.50

238.94

1.5

1.4

268.69

263.50

ug/g

0.45

991

3751

(3035350) Ketones [Presence] in Urine by Test strip

13927

106034

1.52

237.09

4.7

3.8

0.00

estimate

0.81

2052

21899

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3839

21283

1.84

235.57

4.8

3.7

5.79

5.83

kpa

1.71

3720

20686

(3000991) Gas panel - Venous blood

3547

19243

1.87

232.97

8.7

8.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5814

36378

1.67

232.44

3.5

3.0

2.45

2.51

e6/l

0.14

3371

19814

(3030467) Casts [#/volume] in Urine by Automated count

9151

63880

1.55

231.49

3.9

3.2

0.44

0.45

e6/l

0.14

7107

48964

(3002032) Base excess in Venous blood by calculation

3820

21262

1.83

231.04

4.8

3.7

1.75

1.93

mmol/l

2.32

3256

18146

(3009261) Glucose [Presence] in Urine by Test strip

14015

107307

1.51

228.85

4.7

3.8

0.00

estimate

0.06

1799

19952

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4632

27399

1.74

227.43

7.2

7.1

5.09

kpa

0.03

4424

26113

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23377

201074

1.77

226.94

7.7

6.1

41.03

40.36

mmol/mol

22.48

21775

183916

(3027801) Oxygen [Partial pressure] in Arterial blood

4627

27381

1.74

226.77

7.2

7.1

12.03

12.19

kpa

1.27

4409

26093

(3003396) Base excess in Arterial blood by calculation

4619

27374

1.74

225.00

7.3

7.1

0.94

1.12

mmol/l

2.17

3737

21972

(3026493) Urate [Moles/volume] in Serum or Plasma

8672

60105

1.55

224.97

3.2

2.7

4424.90

5037.67

umol/l

0.70

7566

51839

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4961

29992

1.71

224.80

7.5

5.5

1.05

1.03

mmol/l

6.04

4637

27756

(3012544) pH of Venous blood

3917

22173

1.80

223.45

4.8

3.7

7.38

0.10

179

(3021601) Nitrite [Presence] in Urine by Test strip

13845

106059

1.50

223.18

6.3

5.0

0.00

estimate

2.57

1897

20460

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4587

27216

1.73

222.22

3.9

4.3

237.44

247.41

u/l

2.40

4320

25659

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25553

226771

2.22

218.84

14.7

10.9

25.83

26.01

u/l

0.70

24930

217710

(3014111) Lactate [Moles/volume] in Serum or Plasma

3657

20399

1.82

218.64

7.1

6.8

1.35

1.37

mmol/l

0.61

3569

19840

(3014765) Yersinia sp identified in Stool by Organism specific culture

1436

5607

2.52

218.54

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1436

5620

2.52

217.46

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1420

5561

2.52

214.68

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

3219

17348

1.87

214.63

3.9

3.1

4.56

4.54

kpa

0.20

3108

16776

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6936

46163

1.58

212.56

2.0

1.7

1.26

1.35

mg/l

1.53

5413

35946

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9832

70846

1.51

208.90

2.3

2.1

195.04

213.67

u/l

1.35

9241

66113

(36304419) Bacteria [Presence] in Urine

8741

61484

1.53

208.03

3.8

3.2

—

(3042936) Bacteria identified in Isolate by Culture

5146

32013

1.66

207.20

2.2

2.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3175

17232

1.86

206.51

4.7

3.7

103.41

92.00

ng/l

8.03

2801

14621

(3016502) Oxygen saturation in Arterial blood

4171

24571

1.73

205.74

7.6

7.4

95.56

95.53

0.09

4051

23639

(3020779) Urea [Moles/volume] in Serum or Plasma

3670

20910

1.78

203.22

9.6

6.9

10.96

10.38

mmol/l

4.65

3480

19793

(3002582) Erythrocytes [#/volume] in Urine

9635

69678

1.49

198.29

4.0

3.3

78.34

101.08

e6/l

0.89

7525

53706

(3020564) Creatinine [Moles/volume] in Serum or Plasma

25474

226860

2.10

198.00

26.2

18.3

84.44

79.90

umol/l

46.60

25468

226773

(36660697) Celiac disease serology panel - Serum

2762

14523

1.91

197.72

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1430

5844

2.41

196.80

1.8

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1840

8377

2.18

196.15

3.3

3.4

899.50

1602.98

u/ml

0.70

1576

7174

(3026008) Bacteria identified in Urine by Culture

9697

70434

1.49

194.18

3.7

3.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3835

22505

1.73

190.46

8.0

7.9

119.09

121.09

g/l

7.68

3760

21895

(3014007) Fractional oxyhemoglobin in Arterial blood

2782

14889

1.87

188.06

8.7

8.9

93.74

93.83

0.33

2776

14830

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

23363

203181

1.68

187.96

19.8

14.7

75.52

76.97

ml/min/173m2

20.59

19927

168475

(3020682) Albumin/Creatinine [Ratio] in Urine

10170

74965

1.47

187.06

4.3

3.8

11.83

8.76

mg/mmol

7.17

6830

46583

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6396

43017

1.55

182.25

3.4

3.1

2.46

mmol/l

0.32

5496

37632

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2749

14844

1.85

180.25

8.6

8.9

0.66

0.67

0.37

2738

14737

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5491

35832

1.58

178.19

2.3

2.0

30.09

29.91

1.18

5337

34766

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2742

14899

1.84

176.00

8.6

8.8

1.40

1.36

1.14

2728

14786

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

23910

210035

1.71

174.61

5.8

4.9

6.15

6.03

mmol/l

36.92

21990

189463

(3019150) Specific gravity of Urine by Refractometry

6722

46238

1.51

170.62

5.3

4.2

1.02

kg/l

0.49

1022

7074

(3013139) Helicobacter pylori Ag [Presence] in Stool

2523

13494

1.86

170.00

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

9616

71204

1.45

167.34

3.6

3.2

466.27

410.65

mg/l

0.52

6532

44899

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1807

8673

2.06

166.98

1.1

—

(3018418) pH of Serum or Plasma

9355

68958

1.45

166.58

5.2

4.1

7.40

0.42

1230

13562

(3026782) Osmolality of Urine

6689

46156

1.51

166.52

3.6

2.9

536.38

542.23

mosm/kgh2o

0.37

5607

39736

(3009508) Creatinine [Moles/volume] in Urine

9812

72986

1.44

166.35

3.5

3.2

7.33

7.39

mmol/l

0.75

8298

60532

(40761535) Cells panel - Urine sediment

3269

19004

1.73

166.15

4.3

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

25875

233478

2.15

165.72

34.2

22.8

39.41

40.08

22.93

24280

216625

(3037522) Nuclear Ab [Titer] in Serum

4320

27039

1.62

165.50

1.4

1.3

492.70

544.58

titre

1.14

926

5845

(3007853) Bacteria identified in Skin by Aerobe culture

4169

25872

1.64

165.30

2.0

1.8

—

(3007461) Platelets [#/volume] in Blood

25883

233607

2.15

165.16

34.1

22.7

246.34

246.23

e9/l

0.09

25438

226644

(3020630) Protein [Mass/volume] in Serum or Plasma

3393

19979

1.71

164.50

2.5

2.6

66.08

66.36

g/l

1.27

3062

18074

(3004716) Salmonella sp identified in Stool by Organism specific culture

1711

8092

2.09

164.44

1.4

1.3

—

(3035941) MCH [Entitic mass]

25883

233691

2.14

163.55

33.9

22.5

30.34

30.42

8.78

25635

229772

(3010813) Leukocytes [#/volume] in Blood

25886

233732

2.15

163.48

34.1

22.7

6.92

6.76

e9/l

17.41

25354

225935

(3024731) MCV [Entitic volume]

25885

233723

2.14

163.42

34.0

22.6

91.50

91.47

0.48

25636

229798

(3026361) Erythrocytes [#/volume] in Blood

25885

233733

2.14

163.23

34.1

22.7

4.40

4.46

e12/l

68.02

25358

225903

(3000963) Hemoglobin [Mass/volume] in Blood

25886

233773

2.14

162.70

34.3

22.8

132.18

134.83

g/l

138.24

25636

229876

(3013512) EKG study

9272

68566

1.44

160.75

4.9

4.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24349

215799

1.72

160.70

6.0

5.2

2.59

2.69

mmol/l

61.40

22562

196663

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5614

37570

1.54

160.45

3.7

3.3

0.81

0.82

mmol/l

5.80

5247

34949

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23110

202162

1.60

160.17

4.7

4.2

1.36

1.30

mmol/l

32.90

21091

182247

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2050

10470

1.94

158.57

4.9

4.0

24.00

24.14

mmol/l

1.25

1993

10222

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4513

28851

1.59

157.52

9.9

7.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

23685

209127

1.62

149.37

5.3

4.6

1.42

1.46

mmol/l

37.66

21835

190234

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5617

38141

1.51

148.24

2.0

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6497

45466

1.48

147.76

4.6

3.9

565.05

491.51

ng/l

0.21

5440

37272

(3000850) Epithelial cells [#/volume] in Urine

6883

48756

1.46

146.96

3.0

2.7

4.59

5.10

e6/l

3.03

6083

43788

(4200892) Spirometry reversibility

2799

16137

1.73

145.31

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

23829

210988

1.62

145.08

5.3

4.7

4.47

4.60

mmol/l

64.75

22205

193116

(3020961) Endomysium IgA Ab [Titer] in Serum

1632

7953

2.02

144.04

1.1

124.57

223.57

titre

1.35

202

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13993

112511

1.38

143.82

2.7

2.5

—

(3025941) Bacteria identified in Stool by Culture

2077

11008

1.87

142.94

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3438

21032

1.64

142.48

2.6

2.3

6.17

7.47

ug/l

3.95

2988

18245

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2289

12536

1.81

141.66

8.8

9.0

24.19

24.36

mmol/l

1.74

2191

12106

(3004588) Protein electrophoresis panel - Serum or Plasma

2839

16636

1.70

138.52

2.3

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1456

6981

2.05

134.18

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3079

18731

1.64

129.57

1.7

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2452

14086

1.73

128.07

4.3

3.3

125.27

128.47

g/l

9.31

2399

13754

(3028026) IgM [Mass/volume] in Serum or Plasma

2172

12117

1.77

125.66

1.9

1.36

1.34

g/l

0.14

1986

10923

(3005719) IgG [Mass/volume] in Serum or Plasma

2632

15517

1.69

124.79

2.7

2.8

10.61

10.63

g/l

0.06

2436

14144

(3044889) 12 lead EKG panel

18382

156204

1.38

124.49

4.8

4.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1974

10786

1.81

122.39

3.3

2.7

1.26

1.22

0.82

1967

10727

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4002

26212

1.54

122.26

1.9

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1616

8314

1.91

121.27

3.1

2.8

0.32

0.35

u/ml

3.33

927

4767

(3000494) Fungus identified in Specimen by Culture

3890

25450

1.54

119.16

1.6

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1929

10559

1.80

118.76

3.3

2.7

0.66

0.65

0.29

1924

10516

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3983

26212

1.53

118.69

2.0

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2402

14006

1.70

118.35

1.8

1.7

—

(3019060) Gas panel - Arterial blood

2672

16035

1.65

117.97

4.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3230

20315

1.59

117.71

1.7

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

1147

5361

2.09

112.89

1.3

1.2

732.07

1019.02

titre

0.83

164

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1719

9227

1.83

112.70

2.3

3.73

3.74

g/l

0.04

1513

8258

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1722

9250

1.83

112.62

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1723

9261

1.83

112.46

2.3

7.44

7.45

g/l

0.01

1514

8284

(3002385) Erythrocyte distribution width [Ratio]

20780

181348

1.39

111.04

26.5

18.2

16.16

15.23

4.99

20564

177999

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1653

8889

1.83

107.59

4.6

3.9

24.68

24.94

mmol/l

2.76

1525

8141

(3007566) Smooth muscle Ab [Titer] in Serum

1138

5400

2.06

107.47

1.3

1.2

106.70

138.99

titre

0.74

465

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1878

10521

1.76

106.42

5.3

4.0

48.45

47.50

0.93

1868

10401

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1763

9736

1.78

104.93

1.5

12.29

16.17

u/ml

0.60

245

(3021589) Normoblasts [#/volume] in Blood

11847

95585

1.32

104.88

11.8

10.1

0.00

e9/l

2.49

9679

78307

(3022313) Gas panel - Capillary blood

1848

10433

1.74

101.77

4.4

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3532

23346

1.51

101.68

1.8

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1597

8651

1.81

101.31

2.3

2.4

10.22

10.20

g/l

0.07

1377

7618

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1308

6682

1.91

99.86

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1595

8683

1.80

99.49

2.3

2.4

3.01

2.95

g/l

1.71

1389

7709

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

704

2841

2.40

98.91

2.7

2.5

179.56

1120.65

u/ml

1.61

695

2805

(3020891) Body temperature

1689

9368

1.77

98.87

5.3

4.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2918

18633

1.55

98.31

2.3

363.31

376.52

nmol/l

2.97

2679

17103

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2841

18097

1.56

96.66

2.8

61.35

62.65

ml/min/173m2

1.00

1235

7325

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1461

7843

1.82

95.35

2.4

2.6

0.91

1.02

g/l

0.48

1240

6641

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1114

5478

1.98

95.09

1.6

—

(3003338) MCHC [Mass/volume]

19839

173244

1.34

94.69

30.3

20.2

330.80

332.00

g/l

62.72

19711

171881

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2217

13384

1.63

94.55

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3187

20919

1.51

94.30

1.9

1.7

1.61

1.52

7.21

2679

17934

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2154

12920

1.64

94.25

9.8

9.5

—

(3002256) Pathology report gross observation

4208

29207

1.44

93.83

1.4

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2397

14788

1.60

93.47

4.3

3.6

5.13

5.16

kpa

0.98

2259

13932

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1202

6105

1.92

93.29

1.5

1.4

14.02

15.38

iu/ml

0.12

145

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2301

14077

1.61

92.89

4.2

3.5

1.45

1.89

mmol/l

6.41

1728

10516

(3009343) pH of Capillary blood

2366

14604

1.60

92.00

4.2

3.6

7.41

7.42

3.16

214

2019

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1350

7152

1.84

91.89

2.3

37.31

37.44

g/l

0.30

1138

6159

(3019225) pH of Specimen

3489

23481

1.48

91.10

5.2

4.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1297

6822

1.86

90.30

2.4

0.03

g/l

0.04

1161

6217

(3027273) Bicarbonate [Moles/volume] in Venous blood

1942

11477

1.66

89.89

4.5

3.4

25.03

25.28

mmol/l

2.52

1899

11147

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4853

34806

1.40

89.57

1.3

29.97

40.03

iu/ml

4.82

1526

11112

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10467

84233

1.30

89.37

5.5

5.1

3.03

3.56

ug/l

0.79

9420

75174

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1389

7492

1.81

89.12

1.6

199.13

253.64

titre

0.39

363

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4077

28384

1.44

88.93

5.0

4.8

32.71

32.61

0.22

2950

18941

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1483

8235

1.76

86.16

2.4

2.3

444.14

593.16

ug/l

1.09

1393

7791

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1213

6347

1.86

85.79

2.4

0.00

g/l

0.44

1079

5766

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

973

4731

2.00

85.67

1.4

—

(3037121) Protein [Mass/volume] in Urine

1401

7666

1.78

85.60

3.1

0.34

0.32

g/l

0.26

626

3260

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2399

15102

1.57

85.41

7.5

7.2

24.62

24.64

mmol/l

0.09

2314

14371

(3018405) Lactate [Moles/volume] in Arterial blood

1497

8357

1.75

85.36

4.3

4.2

1.38

1.39

mmol/l

0.04

1473

8200

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1194

6249

1.86

84.37

2.4

0.00

g/l

-0.00

1078

5743

(3000492) Spirometry study

2885

18999

1.50

83.32

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4556

32713

1.40

82.72

1.3

14.74

13.86

u/ml

0.19

1566

12039

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10091

81466

1.29

81.77

5.2

4.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1307

7181

1.77

78.63

4.4

4.5

3.86

3.90

mmol/l

2.58

1297

7113

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1358

7588

1.75

77.02

1.1

3.25

6.98

u/ml

0.44

115

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

421

1531

2.65

73.66

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3076

20994

1.45

73.47

3.2

2.9

236.67

218.88

ng/l

1.15

2805

19274

(4035726) Immunohistochemistry procedure

3017

20538

1.45

73.03

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1384

7946

1.70

71.05

2.9

3.4

39.95

45.73

mg/l

1.20

1208

6362

(3034860) Kappa light chains.free [Mass/volume] in Serum

1385

7961

1.70

70.79

2.9

3.4

62.71

72.46

mg/l

0.37

1209

6367

(3024980) IgG subclass 4 [Mass/volume] in Serum

689

3180

2.10

69.89

1.7

1.5

0.70

0.82

g/l

1.88

538

2372

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1434

8352

1.67

69.72

2.8

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

939

4845

1.88

69.23

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1345

7728

1.70

68.81

3.0

3.4

2.56

4.97

ratio

0.91

627

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1084

5864

1.80

68.61

1.5

1.6

17.83

6.98

iu/ml

0.37

254

1335

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

957

5030

1.85

66.55

3.0

3.3

161.66

1007.30

u/ml

5.00

866

4569

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3662

26198

1.39

66.44

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

617

2784

2.14

66.39

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

616

2779

2.14

66.31

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

612

2784

2.12

64.49

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

584

2645

2.13

62.24

1.1

1.56

1.54

g/l

0.61

526

2378

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

610

2819

2.09

61.68

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

620

2896

2.07

60.93

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

609

2831

2.08

60.62

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

913

4922

1.80

58.39

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

913

4923

1.80

58.35

1.4

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

888

4749

1.81

58.32

1.1

6.21

7.88

u/ml

0.34

472

(3017732) Neutrophils [#/volume] in Blood

2175

14509

1.47

57.78

3.0

6.13

5.07

e9/l

1.74

1625

11252

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1068

6051

1.71

57.41

2.6

2.4

3.73

3.63

g/l

1.13

1024

5762

(3052851) Hemolysis interference index of Serum or Plasma

1188

6929

1.67

57.27

3.8

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

893

4825

1.79

56.68

3.6

2.4

34.90

33.47

umol/l

0.93

799

4312

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1879

12229

1.50

56.41

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8250

67173

1.25

56.02

4.8

4.4

21.94

22.03

0.22

4327

34167

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2100

13995

1.47

56.00

8.0

6.8

24.76

24.81

mmol/l

0.23

2082

13859

(3005322) IgE [Units/volume] in Serum or Plasma

1764

11365

1.51

55.57

1.4

1.3

232.69

245.12

u/ml

0.15

1611

10491

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6277

49563

1.27

55.42

1.8

1.7

37263512.35

32043890.58

pmol/l

0.28

5276

40133

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1074

6175

1.69

54.65

1.6

1.18

g/l

0.09

1023

5848

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

260

861

2.90

54.46

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

874

4758

1.78

54.07

3.5

3.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1045

5985

1.69

53.95

1.6

0.24

g/l

0.09

992

5644

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

558

2634

2.04

53.32

3.4

3.3

6.65

9.06

nmol/l

0.51

545

2557

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1048

6091

1.67

51.16

2.3

2.1

90.67

89.75

0.64

1008

5831

(3036489) Thrombin time

1256

7663

1.59

50.41

2.1

1.9

22.06

21.79

0.55

1132

6764

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1873

12451

1.47

50.41

1.3

50.78

56.25

au/ml

0.47

680

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2033

13744

1.45

50.08

2.5

2.4

25.60

25.28

au/ml

0.03

100

913

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

974

5588

1.69

49.94

2.5

2.4

203.79

199.37

0.80

918

5265

(3037756) Immunofixation for Serum or Plasma

935

5317

1.70

49.54

1.5

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1409

8865

1.55

49.41

2.0

1.9

39.62

38.84

u/l

0.71

1207

7678

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1544

9933

1.51

48.82

2.1

2.0

1.90

2.23

ug/l

0.85

1361

8736

(3007930) Methemoglobin/Hemoglobin.total in Blood

1534

9865

1.51

48.59

5.5

5.1

0.88

0.89

0.29

1462

9249

(3029937) Albumin [Presence] in Urine by Test strip

7202

58617

1.23

47.18

5.4

4.2

0.00

estimate

0.15

1789

19517

(3049717) Cytology report of Urine Cyto stain

1535

9946

1.50

46.86

2.9

2.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1545

10042

1.50

46.45

5.4

5.0

1.69

1.64

0.97

1474

9419

(44816559) Phosphatidylethanol [Mass/volume] in Blood

612

3132

1.88

46.28

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

812

4527

1.73

46.22

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

638

3339

1.84

44.97

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

568

2870

1.91

44.67

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

774

4302

1.74

44.54

6.7

5.4

926.79

1290.55

iu/ml

0.31

135

675

(21494890) Protein electrophoresis panel - 24 hour Urine

524

2580

1.96

44.51

1.8

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

1010

6025

1.62

44.45

2.9

3.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

304

1213

2.41

43.97

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

302

1202

2.41

43.92

1.3

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

370

1614

2.20

43.47

1.2

98.00

161.90

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

370

1618

2.20

43.21

1.2

144.04

164.27

titre

0.22

293

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5975

48058

1.24

42.94

3.2

3.1

0.76

0.79

ug/l

0.91

4406

33123

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

669

3615

1.79

42.46

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

500

2470

1.95

42.08

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

863

5030

1.66

41.64

4.6

3.3

7.70

7.64

mmol/l

0.27

849

4934

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

221

776

2.73

41.63

1.2

—

(4062490) Immunoglobulin typing, IgG

429

2018

2.05

41.47

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

860

5015

1.66

41.42

3.5

3.1

0.78

0.81

nmol/l

1.43

679

3876

(3000475) Leukocytes [#/volume] in Synovial fluid

949

5681

1.62

41.17

1.7

1.6

16084.77

14070.03

e6/l

0.56

696

4120

(3024139) IgG subclass 3 [Mass/volume] in Serum

428

2025

2.03

40.73

1.5

1.4

0.42

g/l

0.02

320

1394

(3008037) Lactate [Moles/volume] in Venous blood

898

5318

1.63

40.69

4.5

3.2

1.60

1.61

mmol/l

0.18

885

5204

(3028192) IgG subclass 2 [Mass/volume] in Serum

428

2026

2.03

40.68

1.5

1.4

2.85

2.97

g/l

0.71

317

1391

(3027135) IgG subclass 1 [Mass/volume] in Serum

428

2028

2.03

40.57

1.5

1.4

6.69

6.90

g/l

0.59

318

1393

(3045414) Leukocytes [Presence] in Urine

1486

9850

1.47

40.37

2.0

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

633

3421

1.78

40.17

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1796

12378

1.41

39.47

3.2

2.8

0.29

e6/l

0.01

1754

12097

(40768443) Skin Pathology biopsy report

1504

10054

1.45

39.07

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

782

4523

1.67

38.88

1.2

166.67

137.26

titre

0.13

(3048929) Epstein Barr virus Ab [Presence] in Serum

779

4512

1.67

38.52

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

594

3192

1.79

38.44

1.2

307.08

281.28

u/ml

1.05

391

1999

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1768

12222

1.41

38.15

3.0

3.3

4.36

4.40

pmol/l

0.97

1528

10792

(3003694) ABO and Rh group [Type] in Blood

6667

54841

1.21

37.57

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

1012

6288

1.56

37.44

5.3

4.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1014

6352

1.54

36.17

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

655

3684

1.71

36.16

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

217

813

2.56

36.00

35.9

33.5

7.07

7.25

ug/l

0.61

193

725

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

439

2198

1.92

35.58

3.5

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

947

5868

1.56

35.47

2.4

2.2

120.38

112.53

ug/min

0.23

566

3369

(3000330) Specific gravity of Urine by Test strip

1688

11743

1.40

35.03

4.7

3.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1198

7859

1.48

34.26

1.2

0.66

0.90

u/ml

0.44

131

724

(3042733) HLA Ab [Presence] in Serum

177

620

2.74

33.60

5.6

4.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

653

3757

1.68

33.16

1.6

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

299

1340

2.14

32.96

1.8

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

648

3731

1.67

32.82

1.5

1.4

30.77

18.49

u/ml

1.47

(3033705) Calcium.ionized [Moles/volume] in Venous blood

544

2992

1.75

32.57

2.9

2.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

281

1238

2.18

32.35

2.3

2.1

17.09

27.85

umol/l

1.14

106

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

590

3350

1.70

31.51

1.6

1.4

113.78

117.57

u/ml

0.36

142

775

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

446

2336

1.84

31.48

4.0

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

794

4864

1.57

31.28

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

716

4301

1.60

30.66

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

443

2348

1.81

30.10

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

424

2239

1.82

29.18

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

418

2202

1.82

29.00

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1413

9845

1.39

28.97

2.1

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

253

1118

2.17

28.97

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

253

1118

2.17

28.97

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

871

5541

1.52

28.95

1.3

22.93

41.31

u/ml

2.05

335

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

554

3165

1.68

28.95

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2121

15719

1.31

28.94

2.4

2.1

11.68

12.47

nmol/l

4.27

1837

13849

(40768441) Liver Pathology biopsy report

316

1520

2.00

28.87

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

318

1539

1.98

28.56

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

2146

1.83

28.46

1.1

3.35

3.71

u/ml

0.18

133

870

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

952

6192

1.48

28.42

1.6

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

564

3254

1.67

28.40

7.4

6.0

12.08

11.89

mg/l

0.47

507

2983

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

313

1511

1.99

28.32

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

454

2473

1.77

28.17

1.2

56.35

62.93

u/l

1.38

411

2195

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

704

4303

1.58

28.04

1.2

1.67

5.74

u/ml

3.03

354

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1308

9049

1.40

27.96

1.9

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

211

878

2.30

27.96

2.9

2.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

880

5671

1.50

27.50

2.1

1.9

12.59

11.30

mg/l

4.84

816

5229

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

811

5154

1.52

27.10

1.3

7.57

7.00

u/ml

0.10

114

860

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

801

5087

1.52

26.85

1.3

2.68

6.45

u/ml

1.93

556

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

699

4348

1.55

25.80

1.2

8.49

13.01

u/ml

—

(3010375) cycloSPORINE [Mass/volume] in Blood

211

909

2.23

25.79

32.1

28.8

111.69

112.22

ug/l

0.05

173

772

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

518

2999

1.66

25.78

2.7

2.0

25.61

27.73

mg/l

0.34

123

827

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

865

5630

1.48

25.75

3.5

2.8

1.83

1.64

mg/l

7.91

799

5081

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2724

21135

1.26

25.69

1.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

831

5380

1.49

25.40

1.6

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

281

1359

1.98

25.36

1.2

29.67

25.04

u/l

0.56

235

1158

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

524

3059

1.65

25.25

1.4

1.3

2.24

1.63

nmol/l

0.14

497

2940

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

293

1442

1.95

25.14

1.0

1.1

289.59

289.83

mg/l

0.02

253

1290

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

286

1399

1.96

24.99

1.2

96.80

91.94

u/l

0.31

244

1221

(3023199) Leukocytes [#/volume] in Pleural fluid

523

3072

1.64

24.61

1.5

1970.28

2994.65

e6/l

1.35

372

2251

(1761868) Lipid panel - Serum or Plasma

6489

69534

0.86

24.58

3.4

3.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

552

3295

1.61

24.34

3.1

2.5

658.63

5844.98

u/ml

1.12

208

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

464

2661

1.68

23.98

1.3

1.2

3.71

3.97

u/ml

0.25

212

1182

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

238

1108

2.06

23.90

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

238

1109

2.06

23.84

1.5

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

519

3069

1.63

23.79

1.4

1.3

0.20

0.25

nmol/l

0.61

251

(21494434) Karyotype in Bone marrow

378

2054

1.77

23.74

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

618

3823

1.56

23.41

1.4

1.3

11.81

11.31

u/l

0.34

501

3078

(3003434) Protein [Mass/volume] in Pleural fluid

569

3455

1.58

23.38

1.5

31.15

32.81

g/l

2.42

492

3123

(3023419) Bacteria identified in Sputum by Culture

600

3696

1.56

23.16

2.6

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

434

2474

1.69

22.97

3.6

3.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

516

3076

1.61

22.91

1.1

—

(3005570) Glucose [Moles/volume] in Urine

398

2223

1.72

22.71

1.9

—

1.29

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

420

2387

1.69

22.49

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

420

2388

1.69

22.45

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

397

2224

1.71

22.42

1.4

201042.30

115382.76

e6/l

1.18

284

1516

(3051651) Icteric interference index of Serum or Plasma

271

1352

1.92

22.40

3.8

4.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

589

3642

1.56

22.38

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

589

3642

1.56

22.38

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

662

4212

1.51

22.06

1.4

1.3

60.90

62.14

mmol/l

0.35

526

3363

(3028308) Erythrocytes [#/volume] in Pleural fluid

474

2796

1.63

21.99

1.5

64751.28

55918.09

e6/l

0.23

286

1681

(3024471) HLA-A [Type]

157

642

2.34

21.78

1.0

—

(3036603) Volume of Urine

290

1494

1.86

21.75

1.6

1.5

1919.14

1886.44

0.26

278

1444

(3024932) HLA-DR beta [Type]

154

626

2.36

21.66

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

589

3686

1.54

21.22

1.9

1.8

181.06

196.55

pmol/l

3.50

540

3456

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

473

2814

1.62

21.21

1.4

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

263

1325

1.90

21.15

1.4

13.58

13.32

umol/l

0.21

247

1252

(3006270) Folate [Moles/volume] in Blood

340

1859

1.76

20.97

1.3

1.2

319.54

346.71

nmol/l

1.64

270

1509

(3021788) Differential panel - Synovial fluid

670

4320

1.49

20.96

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

187

838

2.14

20.83

2.5

1.8

3779.04

3588.81

e6/l

0.02

137

569

(3006922) Hepatitis E virus Ab [Presence] in Serum

260

1317

1.89

20.58

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

593

3743

1.52

20.55

1.3

38.07

37.95

u/l

0.01

517

3233

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

451

2674

1.62

20.53

1.4

1.3

—

nmol/l

—

(3004616) Nuclear Ab [Presence] in Serum

435

2569

1.63

20.13

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

761

5084

1.44

19.86

1.9

1.7

42.34

43.70

nmol/l

0.88

730

4911

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

216

1042

1.99

19.76

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

461

2774

1.60

19.76

1.3

1.2

2.92

3.92

u/ml

0.85

157

970

(3033799) Differential panel - Peritoneal fluid

165

723

2.19

19.49

2.0

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

618

3989

1.49

19.27

1.5

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

660

4318

1.47

19.23

1.8

1.6

0.88

0.83

nmol/l

1.10

552

3576

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

706

4680

1.45

19.21

1.1

—

(3003129) Base excess in Capillary blood by calculation

142

588

2.31

19.21

1.9

1.7

0.22

0.61

mmol/l

0.49

133

555

(3044941) Cell count panel - Synovial fluid

573

3644

1.51

19.20

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1301

9532

1.32

19.17

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

737

4932

1.44

19.07

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

447

2696

1.59

18.99

2.2

2.5

1.13

1.22

g/24h

0.30

208

1331

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

243

1238

1.88

18.94

2.4

2.5

0.24

e9/l

0.16

215

1099

(4146454) Self-monitoring of blood glucose

452

2736

1.59

18.92

2.9

2.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

240

1219

1.89

18.89

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

609

3939

1.49

18.81

1.2

35.70

46.02

u/ml

0.76

407

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

240

1224

1.88

18.66

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

491

3047

1.55

18.44

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1176

8541

1.33

18.44

1.8

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

992

7025

1.36

18.41

1.8

1.7

—

(3017704) Immunofixation for Urine

258

1355

1.83

18.29

1.4

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

300

1650

1.74

18.20

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

123

490

2.40

18.19

1.9

1.7

—

(3006462) Nitrate [Presence] in Urine

211

1041

1.94

18.14

4.7

3.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

164

739

2.12

18.09

2.3

1.7

6150.68

11851.74

e6/l

0.72

399

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

249

1299

1.84

18.04

2.4

492.46

534.24

e6/l

0.36

213

1106

(3017181) Myelocytes/100 leukocytes in Blood

2437

19383

1.22

17.97

4.4

4.0

0.96

0.03

958

6919

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

570

3676

1.49

17.88

1.4

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

294

1623

1.74

17.62

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

416

2513

1.59

17.60

1.2

53.53

57.09

u/ml

0.11

180

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

457

2.43

17.59

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

604

3954

1.47

17.58

1.8

4.83

4.98

mmol/24h

0.52

530

3423

(3026692) Albumin [Mass/volume] in Peritoneal fluid

137

581

2.26

17.57

1.7

1.4

13.31

13.53

g/l

0.10

108

445

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

304

1697

1.72

17.51

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

351

2046

1.65

17.19

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

191

933

1.96

16.94

1.5

1.6

10.25

8.85

ug/l

0.27

181

845

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

349

2044

1.64

16.79

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

349

2044

1.64

16.79

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

349

2044

1.64

16.79

1.7

1.6

—

(40768446) Kidney Pathology biopsy report

166

774

2.05

16.78

1.7

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

352

2067

1.63

16.76

1.5

1.4

20.30

29.41

iu/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1357

10184

1.29

16.71

3.0

3.9

46.49

66.86

u/ml

2.21

1301

9817

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

617

4100

1.45

16.64

1.5

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

212

1082

1.88

16.51

1.2

1.1

3.00

4.61

iu/ml

1.32

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

389

2350

1.59

16.49

1.4

1.3

363.67

494.14

u/l

1.20

363

2233

(1002224) Polysomnography panel

972

6986

1.34

16.40

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

150

683

2.10

16.17

1.9

1.5

2.05

2.03

umol/l

0.10

144

633

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

317

1831

1.66

16.12

1.4

1.3

32.84

34.16

u/l

0.26

252

1484

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

217

1130

1.84

15.89

1.2

—

(3012441) Differential panel - Pleural fluid

428

2666

1.54

15.88

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

201

1022

1.88

15.86

2.5

1.9

91.47

97.68

1.51

191

958

(3043410) Blood group antigens tested for on Red Blood Cells

133

586

2.17

15.61

1.7

1.9

—

(3045788) Cell count panel - Pleural fluid

386

2359

1.57

15.60

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

321

1878

1.64

15.55

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

122

521

2.24

15.46

1.2

318.09

283.34

pmol/l

0.24

373

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

766

5357

1.38

15.44

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

459

2922

1.51

15.41

1.4

77.50

57.73

mu/l

0.91

401

2590

(40768806) Pleura Pathology biopsy report

429

2695

1.53

15.33

1.5

—

(3008898) HLA-B27 [Presence]

731

5082

1.38

15.28

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

364

2206

1.58

15.26

2.0

1.9

1210.36

3377.64

u/l

2.39

105

797

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1509

11603

1.26

15.21

1.2

119.86

137.72

iu/ml

1.11

537

4248

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

493

3194

1.48

15.19

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

206

3.02

15.08

1.6

52.91

44.13

umol/l

0.98

206

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

261

1459

1.71

15.04

1.6

1.5

6.40

7.06

u/l

0.31

211

1163

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

155

736

2.02

14.97

1.6

1.7

16353.72

34708.49

u/ml

0.41

102

(3036782) Glucose [Moles/volume] in Pleural fluid

378

2323

1.56

14.93

1.4

1.3

6.89

6.28

mmol/l

3.02

342

2156

(3039000) Anion gap in Blood

767

5405

1.36

14.76

7.2

6.8

11.04

11.21

mmol/l

0.76

703

4874

(3018572) Chloride [Moles/volume] in Blood

767

5406

1.36

14.74

7.2

6.8

105.23

105.00

mmol/l

0.62

703

4875

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6759

59025

1.12

14.49

1.7

1.41

1.35

mmol/l

6.02

5865

48550

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

305

1795

1.63

14.47

1.5

1.4

13.46

12.89

u/l

0.80

296

1723

(21494755) Public health laboratory ask at order entry panel

1094

13264

0.78

14.23

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

303

1789

1.62

14.20

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

180

919

1.88

14.09

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

225

1230

1.75

14.08

9.9

10.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

781

5573

1.35

13.88

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

255

1453

1.68

13.74

2.4

2.5

662.90

657.86

e6/l

0.03

244

1385

(3025159) Blasts/100 leukocytes in Blood

2151

17335

1.20

13.74

4.4

4.0

0.09

0.38

4.86

692

4984

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

106

451

2.25

13.61

3.2

2.9

7.09

7.38

mg/l

0.17

354

(3021440) Promyelocytes/100 leukocytes in Blood

2271

18421

1.19

13.50

4.5

4.0

0.11

0.02

800

5999

(3008757) Leukocyte morphology finding [Identifier] in Blood

412

2640

1.50

13.47

3.9

3.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

417

2680

1.49

13.44

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

423

2733

1.48

13.28

1.3

310.88

327.73

pmol/l

0.16

373

2332

(3035637) Corticotropin [Mass/volume] in Plasma

398

2546

1.50

13.13

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

506

3397

1.43

13.02

1.9

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

529

2.12

12.95

1.4

25.30

40.05

g/l

0.71

413

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

317

1939

1.57

12.86

1.2

1.1

95.30

95.42

0.03

296

1796

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

249

1438

1.66

12.79

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

518

3504

1.42

12.79

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

250

1446

1.66

12.77

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

154

775

1.90

12.66

1.9

1.5

28.17

29.94

umol/l

1.14

149

743

(40759836) Histone Ab [Presence] in Serum by Immunoblot

248

1436

1.65

12.62

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

322

1986

1.55

12.61

2.6

2.2

727.81

673.73

1.31

226

1309

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

249

1445

1.65

12.56

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

249

1446

1.65

12.53

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1439

1.65

12.52

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

398

2572

1.48

12.52

1.2

1.1

119.82

117.31

0.75

368

2285

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

348

2188

1.52

12.49

1.4

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

103

450

2.19

12.45

1.2

82.97

65.21

mu/l

0.33

323

(3015235) Bicarbonate [Moles/volume] in Capillary blood

840

6178

1.31

12.14

3.2

3.1

24.39

24.90

mmol/l

3.08

823

6042

(3002179) Metamyelocytes/100 leukocytes in Blood

2163

17634

1.19

12.12

4.1

3.9

0.68

0.69

0.08

843

5936

(3020717) Zinc [Moles/volume] in Serum or Plasma

166

870

1.83

12.04

1.6

1.4

22.93

25.13

umol/l

0.42

160

816

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

304

1871

1.56

12.04

1.4

1.3

10.93

13.76

u/l

2.19

283

1725

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

347

2201

1.51

11.97

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

210

1183

1.70

11.89

1.2

361.14

325.66

u/l

0.09

191

1104

(3016244) Insulin [Units/volume] in Serum or Plasma

161

840

1.83

11.86

2.5

3.1

29.17

24.30

mu/l

0.72

153

781

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

209

1177

1.70

11.85

2.1

2.2

93.00

110.00

ug/min

0.15

260

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

423

2.19

11.81

2.6

2.3

106.98

178.31

au/ml

0.77

(4094501) Cardiovascular stress test using bicycle ergometer

838

6194

1.30

11.69

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

521

3599

1.39

11.44

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

604

4276

1.36

11.39

2.0

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

314

1972

1.53

11.38

1.4

1.3

1.54

1.41

nmol/l

1.31

289

1780

(3036670) Protein [Mass/volume] in Synovial fluid

144

737

1.87

11.30

1.3

39.59

40.08

g/l

0.16

382

(3011412) CD3 cells [#/volume] in Blood

311

1955

1.52

11.23

2.4

2.3

1.12

1.15

e9/l

0.20

279

1793

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

582

4114

1.36

11.10

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

292

1817

1.54

11.06

1.5

1.6

21.62

25.32

u/ml

0.97

380

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

474

3242

1.40

11.06

1.7

1.9

25.58

24.68

ug/l

0.08

465

3171

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

658

4741

1.33

11.05

1.7

5.01

14.95

iu/l

1.05

186

1617

(3047189) Immunofixation for 24 hour Urine

205

1172

1.67

11.03

1.6

1.8

—

(3020491) Glucose [Moles/volume] in Blood

255

1542

1.58

10.95

1.6

2.0

7.17

7.21

mmol/l

0.07

160

1080

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

515

3579

1.38

10.93

1.3

211.52

210.67

miu/ml

0.02

190

1420

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

482

3316

1.39

10.87

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

218

1273

1.64

10.81

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1032

7906

1.26

10.81

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

503

2.03

10.77

2.6

2.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

332

2137

1.49

10.73

1.1

2.15

1.91

iu/ml

0.12

(3001186) Copper [Moles/volume] in Serum or Plasma

434

2.12

10.72

1.3

1.2

17.20

16.59

umol/l

0.73

387

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

372

2456

1.45

10.57

1.1

1.86

1.44

u/ml

0.27

183

1182

(3044007) Cell count panel - Peritoneal fluid

132

672

1.88

10.56

2.3

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

275

1708

1.54

10.53

1.2

83.33

81.77

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

217

1275

1.63

10.52

3.0

1.8

18.27

15.88

nmol/l

4.24

209

1183

(3028433) Virus identified in Specimen by Culture

139

723

1.84

10.41

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

123

615

1.91

10.40

1.2

0.31

g/l

0.06

495

(3047181) Lactate [Moles/volume] in Blood

997

7643

1.25

10.40

6.7

5.9

1.25

1.33

mmol/l

2.05

890

6778

(3038026) Centromere Ab [Units/volume] in Serum

281

1759

1.53

10.39

1.2

46.16

56.00

u/ml

0.15

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

209

1221

1.64

10.37

1.5

6.25

6.00

u/l

0.11

168

1030

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

275

1714

1.54

10.37

1.2

45.31

44.26

u/ml

0.02

136

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

164

898

1.75

10.35

3.0

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

125

630

1.90

10.33

2.7

3.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

247

1505

1.57

10.31

1.3

63.33

73.02

titre

0.18

129

(40761536) Microorganisms panel - Urine sediment

1683

18874

0.84

10.30

5.2

4.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

111

540

1.97

10.18

1.3

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

371

2467

1.44

10.17

3.2

3.4

58.65

57.41

0.53

314

2058

(3004809) Band form neutrophils/100 leukocytes in Blood

557

3967

1.35

10.15

3.4

1.43

1.56

0.42

488

3499

(3045142) Bone marrow Pathology biopsy report

395

2658

1.42

10.15

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

351

2311

1.46

10.14

2.3

2.0

1.92

4.10

titre

0.87

(3018133) Calcium [Moles/volume] in Urine

244

2.47

10.12

1.3

1.6

2.42

2.72

mmol/l

0.49

213

(3022493) Free Hemoglobin [Mass/volume] in Plasma

169

942

1.72

10.03

8.1

4.2

2074.82

1649.14

mg/l

0.11

129

661

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

307

1974

1.49

10.01

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

262

1629

1.54

10.01

1.2

2.31

9.36

u/ml

2.02

104

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

190

1096

1.66

9.93

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

184

1055

1.67

9.85

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

134

702

1.83

9.84

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

115

574

1.92

9.81

1.2

111.11

113.02

0.27

507

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

220

1323

1.59

9.74

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

2.35

9.65

4.7

5.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

319

2084

1.47

9.63

1.1

0.71

1.09

u/ml

1.02

123

800

(3014051) Protein [Presence] in Urine by Test strip

785

5906

1.28

9.62

3.3

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

186

1078

1.65

9.57

1.6

7.41

11.67

umol/l

2.11

135

765

(3003888) Timothy IgE Ab [Units/volume] in Serum

329

2165

1.46

9.57

1.1

2.89

3.60

u/ml

0.63

157

992

(3014271) Vancomycin [Susceptibility]

224

1363

1.57

9.45

3.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

249

1553

1.54

9.41

1.3

139.44

445.55

titre

2.21

137

(3020191) Ethanol [Moles/volume] in Serum or Plasma

252

1581

1.53

9.28

1.3

1.4

1.30

1.32

promille

0.07

193

1199

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3003

25621

1.13

9.04

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

142

779

1.74

8.98

1.4

1.3

3.47

3.50

mmol/l

0.03

132

712

(3021387) Prolactin [Units/volume] in Serum or Plasma

538

3886

1.33

8.98

1.8

275.90

306.22

mu/l

1.23

499

3553

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

434

3042

1.37

8.84

1.1

66.97

3994.99

iu/ml

0.56

613

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

132

2.90

8.80

2.2

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

229

1425

1.54

8.79

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

150

841

1.71

8.79

2.2

2.0

51.86

55.85

ug/l

0.36

150

816

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

116

604

1.84

8.74

1.1

—

(3016038) Potassium [Moles/volume] in Urine

242

1527

1.52

8.71

1.2

1.1

34.01

34.52

mmol/l

0.12

212

1282

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

429

3009

1.37

8.71

1.6

1.5

59.14

59.57

0.08

299

1885

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

379

2608

1.39

8.65

1.1

7.51

11.69

au/ml

—

118

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

130

704

1.77

8.62

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

221

1372

1.54

8.58

1.5

1.3

1.26

1.31

u/ml

0.04

140

786

(3006245) CD3-CD19+ cells/100 cells in Blood

120

636

1.80

8.55

2.2

2.0

9.78

10.59

0.27

111

571

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

275

1793

1.47

8.45

1.8

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

149

844

1.69

8.43

1.5

1.6

2.86

7.45

nmol/l

0.95

124

713

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

451

3212

1.35

8.32

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

195

1186

1.57

8.31

2.8

39.36

37.53

0.67

116

668

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

115

608

1.81

8.28

1.5

1.4

19.09

22.58

0.81

510

(3035320) C reactive protein [Mass/volume] in Body fluid

248

1591

1.49

8.27

2.4

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

118

629

1.79

8.27

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

111

581

1.83

8.26

7.5

5.7

63.51

70.98

2.15

473

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

120

644

1.78

8.22

2.1

1.9

28.64

30.36

0.66

114

599

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

247

2.28

8.06

2.0

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

433

3087

1.34

7.95

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

672

5086

1.27

7.92

1.3

570.83

574.97

mg/l

0.03

635

4833

(3022689) Creatine [Moles/volume] in Urine

117

632

1.77

7.87

1.4

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

408

1.97

7.86

4.0

2.8

14.45

14.78

ml/dl

0.45

380

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.45

7.64

1.0

36.43

35.03

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

246

1604

1.47

7.61

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

128

2.76

7.53

1.4

1.2

52.93

43.42

mg/l

1.12

(3000034) Microalbumin [Mass/volume] in Urine

316

2163

1.40

7.51

3.6

2.9

64.23

46.05

mg/l

0.45

230

1556

(3024263) Appearance of Synovial fluid

197

1231

1.53

7.50

1.3

1.4

—

(3022621) pH of Urine by Test strip

1776

14811

1.15

7.49

3.7

3.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.58

7.46

1.0

1.1

182.63

184.73

ug/g

0.01

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

596

4485

1.27

7.40

1.3

3.85

3.83

mmol/l

0.26

554

4221

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

296

2010

1.41

7.38

1.8

1140.00

2499.24

titre

0.70

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

257

2.19

7.37

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

550

4105

1.28

7.30

3.7

3.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

676

1.71

7.27

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

335

2.03

7.23

1.3

1.2

1289.80

143.07

ng/l

0.46

231

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

147

867

1.62

7.19

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

281

1900

1.42

7.19

1.8

1.9

3.79

4.08

mg/l

0.76

266

1808

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

153

912

1.60

7.17

1.4

61.75

63.37

0.23

126

742

(3020393) Adenovirus Ag [Presence] in Stool

188

2.39

7.16

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

1200

1.52

7.12

1.5

1.3

1.18

1.24

nmol/l

0.31

144

921

(4212803) Bone marrow aspirate examination

213

2.29

7.06

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

192

1212

1.52

7.00

1.2

1.1

93.72

84.52

u/l

0.86

179

1078

(3002079) Sodium [Moles/time] in 24 hour Urine

151

904

1.60

6.96

1.2

160.61

161.15

mmol/24h

0.02

151

904

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

192

1214

1.51

6.95

1.2

1.1

30.25

24.97

u/l

0.59

177

1076

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

717

5558

1.24

6.91

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

429

1.87

6.83

2.0

1.9

2144.35

1139.04

e6/l

0.25

229

(3016750) Collection duration of Urine

220

1439

1.46

6.76

2.5

2.1

492.68

500.57

min

0.69

179

1024

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

425

1.87

6.71

1.1

—

(4281824) Cell count and differential, peritoneal fluid

336

2371

1.36

6.68

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

438

3215

1.31

6.64

1.6

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

353

1.95

6.63

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

356

2538

1.34

6.63

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

406

2952

1.32

6.60

5.0

4.7

355.22

357.91

umol/l

0.14

349

2499

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

206

1338

1.47

6.57

1.7

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

204

2.25

6.42

2.4

2.2

55.66

60.47

0.33

129

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

278

1919

1.39

6.37

1.1

73.98

69.46

au/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

717

5611

1.23

6.36

2.4

2.2

125.79

128.97

g/l

2.29

477

4085

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

189

1220

1.48

6.25

1.1

2.21

7.17

nmol/l

2.18

233

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

352

2532

1.33

6.20

1.1

—

(3023410) Appearance of Cerebral spinal fluid

280

1945

1.38

6.19

1.7

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

252

1722

1.40

6.14

4.3

5.0

113.65

115.02

u/ml

0.01

507

(1175426) CD3 cells/100 lymphocytes in Blood

226

1517

1.43

6.10

2.1

2.0

70.95

71.97

0.44

215

1445

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

157

980

1.53

6.10

1.9

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

291

2.00

6.10

1.2

1.3

339137.11

228278.54

nmol/l

0.17

237

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

371

1.88

6.08

2.1

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1152

1.49

6.02

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

117

685

1.63

5.98

1.5

16.12

15.84

pmol/l

0.11

105

565

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

221

1485

1.42

5.94

2.1

1.9

16.71

16.19

0.28

215

1438

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

157

2.37

5.92

2.3

19.90

15.51

0.28

(3023511) Choriogonadotropin [Units/volume] in Urine

152

950

1.53

5.89

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

251

1729

1.39

5.86

2.1

39.64

37.47

1.25

241

1693

(3025130) Human papilloma virus identified in Specimen

265

1842

1.38

5.86

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

197

1300

1.45

5.85

1.1

1.2

49.78

46.51

mg/l

0.27

181

1079

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1376

11489

1.15

5.77

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

518

1.72

5.75

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

161

1025

1.50

5.73

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

541

1.70

5.69

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

786

8929

0.84

5.69

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

103

592

1.66

5.68

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

1183

1.46

5.67

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.23

5.65

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

235

2.07

5.63

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

274

1.99

5.61

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

128

780

1.57

5.58

1.6

2.1

164.74

161.56

0.16

118

720

(3044290) Cell count panel - Cerebral spinal fluid

538

4146

1.24

5.57

1.4

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

545

4209

1.24

5.53

1.4

142.82

176.72

pmol/l

1.18

531

4099

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

322

1.90

5.53

1.3

1.2

—

(3035880) pH of Pleural fluid

211

1426

1.42

5.53

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

136

842

1.54

5.53

1.6

1.4

—

(3000012) Reticulocyte production index

480

3655

1.26

5.52

2.0

2.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

350

1.86

5.49

1.7

1.5

106.79

111.89

ug/l

0.16

288

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

128

784

1.56

5.46

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

166

1075

1.48

5.46

1.1

10.57

9.80

iu/ml

0.12

232

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

1114

1.47

5.46

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

351

1.85

5.44

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

302

2169

1.33

5.44

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

534

1.68

5.43

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

187

1241

1.44

5.43

1.1

332.67

307.59

mg/l

0.40

174

1078

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

535

1.68

5.40

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

152

971

1.50

5.36

1.9

2.0

—

(1616796) Gas panel - Central venous blood

690

5480

1.21

5.34

4.2

3.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

152

972

1.50

5.33

1.9

2.0

—

(3048879) Bone marrow aspiration report

124

759

1.56

5.32

1.6

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

138

866

1.52

5.30

1.1

2.11

6.02

u/ml

3.11

131

(3041096) Erythrocytes [Presence] in Urine by Automated

6197

56033

1.07

5.29

4.3

3.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

495

1.70

5.29

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

561

1.65

5.25

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

572

1.64

5.13

1.4

1.6

0.41

0.38

ug/l

0.34

370

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

537

1.66

5.08

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

122

2.43

4.99

5.5

4.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

490

1.68

4.96

1.3

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

230

1610

1.37

4.95

1.4

0.31

0.28

nmol/l

0.32

170

1149

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

302

1.87

4.89

2.4

2.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

485

1.67

4.88

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

118

2.43

4.85

1.7

1.6

250.72

200.45

ng/l

0.55

104

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

230

1.99

4.82

1.2

78.23

112.81

ug/l

1.10

144

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

130

2.35

4.82

1.4

1.3

14.94

17.88

pmol/l

0.53

109

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

569

1.61

4.76

1.8

1.6

9.46

9.16

ug/l

0.28

569

(3010503) CD19 cells [#/volume] in Blood

195

1339

1.39

4.74

2.5

0.15

0.41

e9/l

1.89

187

1294

(3042631) Mycobacterium sp identified in Specimen

460

3555

1.24

4.71

2.9

2.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

320

1.82

4.70

1.4

1.2

46.47

41.12

mg/l

0.32

269

(3033923) Metanephrine [Moles/time] in 24 hour Urine

476

1.67

4.69

1.2

1.1

0.73

0.81

umol/24h

0.18

225

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

166

1110

1.43

4.69

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

131

838

1.49

4.65

1.6

2.1

187.68

299.12

ug/l

0.22

125

795

(3006576) Bicarbonate [Moles/volume] in Blood

135

869

1.49

4.65

6.9

6.3

25.01

25.03

mmol/l

0.03

122

785

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

115

2.41

4.62

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

154

1019

1.45

4.61

1.2

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

598

1.58

4.56

1.2

1.3

3.07

3.24

umol/l

0.20

549

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

562

4451

1.21

4.55

1.4

23.78

31.04

e6/l

0.44

445

3450

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

728

1.52

4.52

1.3

1.4

56.58

57.20

0.06

622

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

518

1.62

4.51

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

290

1.84

4.51

2.2

2.5

74.89

76.14

pmol/l

0.03

253

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

562

4456

1.21

4.50

1.5

1.4

5653.46

1406.60

e6/l

0.57

462

3648

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

204

1426

1.37

4.47

2.2

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

217

1.98

4.47

1.6

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

490

1.64

4.47

1.9

1.8

9.27

9.07

mg/l

0.12

389

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

218

1.97

4.42

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

604

1.57

4.39

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

330

2477

1.27

4.38

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

107

666

1.54

4.35

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

260

1.87

4.32

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

994

1.43

4.30

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

175

2.07

4.29

1.2

1.3

1.19

1.04

ml/s/173m2

0.30

108

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.88

4.28

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

235

1695

1.33

4.22

1.1

—

(3008295) Osmolality of Serum or Plasma

303

2264

1.28

4.19

1.4

279.19

277.21

mosm/kgh2o

0.68

219

1751

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

1152

1.39

4.17

1.7

1.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

333

1.75

4.16

1.3

20.04

24.75

0.65

254

(3012494) Peanut IgE Ab [Units/volume] in Serum

362

1.72

4.14

1.1

1.0

0.77

0.78

u/ml

0.01

181

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

222

1594

1.33

4.12

1.2

1.3

2.07

2.23

mmol/l

1.35

204

1480

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

313

1.77

4.12

1.0

1.1

—

(3034426) Prothrombin time (PT)

600

1.55

4.08

1.3

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

199

1.97

4.03

1.2

1.0

—

2.00

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

130

859

1.45

3.99

12.1

12.4

0.64

mmol/l

0.05

121

782

(3028717) Thiamine [Mass/volume] in Blood

208

1.93

3.91

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

137

918

1.43

3.91

1.2

1.1

1.22

1.10

u/l

0.26

448

(3009871) Measles virus Ab [Titer] in Serum

592

1.53

3.89

1.6

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

111

715

1.48

3.88

1.4

23.60

20.50

0.54

644

(3009015) Lactate [Moles/volume] in Synovial fluid

264

1.81

3.84

1.3

6.17

6.59

mmol/l

0.13

128

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

127

843

1.44

3.82

1.1

515.72

733.62

ng/l

0.30

214

(3010370) Gastrin [Moles/volume] in Serum or Plasma

328

1.72

3.81

1.5

1.8

61.37

58.46

pmol/l

0.07

272

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

972

1.41

3.78

1.4

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

245

1.83

3.77

1.0

0.83

1.87

u/ml

0.42

197

(3017569) Oxygen content in Arterial blood

165

1152

1.37

3.72

2.3

2.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

331

1.70

3.70

3.0

2.5

96.90

73.57

mg/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.39

3.65

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

110

2.26

3.65

4.3

3.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

120

796

1.44

3.64

1.4

2.31

2.68

0.21

666

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

113

741

1.46

3.64

1.3

334.18

250.37

ug/l

0.16

401

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1322

13986

0.90

3.60

1.9

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

298

1.73

3.60

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

183

1307

1.34

3.59

1.9

3.16

2.53

u/field

0.37

122

911

(3005011) Chlamydia sp Ab [Titer] in Serum

236

1.82

3.56

2.0

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

737

1.45

3.56

1.1

1628.07

1532.40

miu/ml

0.39

112

737

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

118

2.19

3.52

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

316

1.69

3.47

1.2

1.3

58.58

49.91

0.64

141

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.71

3.46

1.4

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

297

2272

1.25

3.46

1.6

1.5

26.41

29.07

0.71

203

1387

(3028626) Oxygen [Partial pressure] in Capillary blood

653

5380

1.16

3.45

3.0

2.9

7.93

7.96

kpa

0.26

639

5257

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

246

1.79

3.43

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

274

2080

1.26

3.42

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

172

1.94

3.38

1.2

24.33

23.82

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.05

3.37

1.4

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.45

3.36

1.4

1.3

141.60

122.79

ug/l

0.13

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

386

1.61

3.32

1.3

1.4

12.06

10.42

0.23

192

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

1168

1.34

3.31

3.8

3.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

147

2.01

3.31

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

454

1.56

3.30

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

175

1.91

3.23

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

129

2.07

3.23

1.1

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

450

5082

0.84

3.23

4.5

3.5

28.65

27.52

mg/l

0.24

278

3248

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

237

1.77

3.22

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

257

1953

1.26

3.20

2.0

2.1

3.01

2.19

u/field

0.86

113

779

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

1.78

3.18

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

197

1.84

3.15

1.0

0.58

0.47

u/ml

0.06

126

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

304

1.67

3.12

2.8

2.7

0.62

0.51

u/field

0.35

304

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

561

1.48

3.11

1.3

103.78

139.29

nmol/l

1.80

403

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

356

1.61

3.10

1.2

79.32

84.38

0.36

119

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

250

1.72

2.99

1.1

15.62

19.88

u/l

1.15

165

(3008536) Aspergillus sp Ab [Presence] in Serum

458

1.52

2.99

1.9

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

861

1.38

2.98

1.7

78.71

112.88

umol/l

1.59

449

(3020874) Milk IgE Ab [Units/volume] in Serum

109

741

1.41

2.97

1.1

1.0

1.56

1.22

u/ml

0.13

238

(21491868) Cryoglobulin [Mass/volume] in Serum

110

750

1.40

2.95

1.2

0.22

0.64

g/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

354

1.59

2.94

1.2

74.50

74.58

0.00

112

(3010726) Horse dander IgE Ab [Units/volume] in Serum

248

1899

1.25

2.93

1.1

1.12

1.06

u/ml

0.05

130

884

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

161

1.90

2.93

1.2

0.30

0.21

nmol/l

0.34

107

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

347

1.60

2.92

1.6

1.4

74.48

72.36

0.53

335

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

602

1.44

2.89

9.7

7.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

117

811

1.38

2.86

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

541

1.47

2.85

1.1

81.52

86.52

0.78

269

(43055514) Macroprolactin [Presence] in Serum or Plasma

254

1.69

2.84

1.7

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

1173

1.31

2.84

2.2

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.67

2.82

1.4

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

198

1.78

2.81

1.1

1.0

—

(3021901) Oxygen saturation in Capillary blood

560

4642

1.15

2.80

3.1

2.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

134

955

1.34

2.76

1.5

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

202

1523

1.27

2.75

2.1

2.6

—

(40757373) Influenza virus identified in Isolate

454

1.49

2.70

1.8

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

310

1.60

2.69

6.2

4.7

53.93

50.13

ug/min

0.19

254

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.29

2.67

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

519

1.45

2.63

9.9

7.7

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.21

2.61

1.1

1.0

0.10

0.06

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

528

1.45

2.61

1.1

83.15

86.08

0.26

265

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.39

2.60

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

343

1.56

2.60

1.7

1.4

2293.73

742.82

mu/l

0.40

331

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

128

1.94

2.57

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

190

1.76

2.56

1.1

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.15

2.56

1.1

1.0

0.26

0.13

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

170

1268

1.28

2.55

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

104

723

1.37

2.54

1.0

1.90

0.67

u/ml

0.50

165

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

205

1.72

2.53

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

103

2.04

2.49

1.8

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

117

1.96

2.44

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

169

1268

1.27

2.44

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

1.81

2.44

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

104

2.02

2.43

7.3

7.6

—

(3052592) Norovirus Ag [Presence] in Stool

482

1.45

2.40

1.5

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.53

2.39

3.0

3.5

—

(3025577) Chromium [Mass/volume] in Blood

210

1621

1.24

2.39

2.0

2.1

2.30

2.33

ug/l

0.04

172

1347

(3030313) Adrenal Ab [Titer] in Serum

106

1.98

2.33

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

402

1.47

2.26

1.6

54.88

93.41

au/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

116

839

1.32

2.24

2.4

2.3

55.50

53.09

umol/l

0.29

695

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

318

1.53

2.23

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

259

1.59

2.19

2.0

16.00

17.62

umol/l

0.59

259

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

157

1.76

2.18

1.1

9.28

10.90

u/l

0.20

157

(3011288) Drugs identified in Urine by Screen method

264

2109

1.20

2.17

2.3

3.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.18

2.16

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

118

861

1.31

2.15

18.1

15.6

1305.63

2544.18

nmol/l

0.57

111

824

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

246

1.59

2.13

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

166

1267

1.25

2.13

5.9

6.4

—

(3027874) Urate [Moles/volume] in Urine

2.11

2.12

1.2

1.0

1.55

1.72

mmol/l

0.21

(3050794) Legionella sp Ab [Presence] in Serum

195

1.67

2.11

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

199

1555

1.22

2.07

1.2

9.98

9.25

mmol/l

1.27

187

1469

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.18

2.07

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.18

2.07

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.18

2.07

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.18

2.07

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.18

2.07

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.18

2.07

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.44

2.06

1.0

264.43

386.77

umol/l

—

(3002619) Bacteria identified in Specimen by Culture

466

1.41

2.06

1.2

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

317

1.51

2.06

1.1

1.2

—

(3004451) EKG impression Narrative

165

1267

1.24

2.02

1.2

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

154

1.74

2.02

1.1

1.0

0.18

0.65

u/ml

0.42

115

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.93

1.99

1.8

1.5

5.06

3.08

mg/l

0.57

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.93

1.99

1.8

1.5

0.73

2.05

mg/l

1.74

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

162

1.71

1.99

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

575

1.36

1.98

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

192

1.64

1.96

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

141

1069

1.26

1.95

1.1

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

345

1.47

1.94

1.0

—

(40762814) Titanium [Mass/volume] in Blood

472

1.40

1.94

2.3

2.87

3.70

ug/l

1.80

163

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

545

1.37

1.93

1.1

110.76

104.94

0.51

494

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

409

1.42

1.92

1.0

1.1

1.73

3.57

pmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

2.34

1.90

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

211

1675

1.20

1.90

2.0

4.51

3.68

ug/l

0.65

191

1537

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

122

1.80

1.88

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

122

1.80

1.88

1.5

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

158

1.69

1.87

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

144

1.72

1.85

1.2

1.6

0.74

0.76

umol/l

0.04

107

(3022229) Phosphate [Moles/volume] in Urine

2.22

1.84

1.2

1.1

13.45

17.23

mmol/l

0.56

(3017509) Phencyclidine [Presence] in Urine

109

1.84

1.6

1.3

—

(3036180) Methadone [Presence] in Urine

470

1.38

1.82

1.6

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

192

1519

1.21

1.81

1.3

1.1

—

(3014891) Appearance of Pleural fluid

351

1.44

1.80

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

628

5418

1.11

1.79

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

328

1.46

1.78

1.6

1.2

768.92

161.65

u/l

0.43

233

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.73

1.75

2.5

5.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

252

1.52

1.74

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

155

1.66

1.71

1.0

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.85

1.71

1.3

1.6

0.36

0.20

u/l

0.26

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

649

1.31

1.70

2.0

2.1

48.89

39.08

u/l

0.18

592

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

109

817

1.27

1.70

13.6

11.1

765.09

827.49

nmol/l

0.71

102

780

(3000285) Sodium [Moles/volume] in Blood

316

1.45

1.70

1.1

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

608

1.32

1.69

1.4

1.3

36.63

36.39

0.02

408

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.96

1.69

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

284

2343

1.16

1.67

1.2

7.55

7.66

mmol/l

0.23

234

2008

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

350

1.42

1.64

1.8

2.3

—

(3015183) Erythrocyte sedimentation rate

102

763

1.28

1.63

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

107

1.78

1.62

1.9

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1981

19902

0.95

1.61

4.7

3.9

1.22

1.23

mmol/l

1.55

1797

17272

(3024869) Neuronal Ab [Presence] in Serum

449

1.36

1.60

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.91

1.59

1.2

1.1

218.34

288.13

nmol/l

1.47

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

152

1.63

1.56

6.1

4.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

314

1.43

1.56

1.7

1.4

66.09

73.18

0.79

265

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

167

1.60

1.56

2.2

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.46

1.56

1.4

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.46

1.56

2.8

2.3

1.73

1.78

mu/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

192

1546

1.19

1.55

1.1

1.0

3.57

3.24

u/ml

0.11

567

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.03

1.53

1.2

1.4

214.98

557.78

nmol/l

4.02

(3023323) Follitropin [Units/volume] in Serum or Plasma

587

5100

1.10

1.51

1.4

1.3

31.03

34.91

iu/l

1.93

496

4393

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.86

1.50

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

136

1064

1.22

1.49

1.1

1.05

1.08

ratio

1.71

378

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

132

1.66

1.49

1.3

1.1

13.23

14.60

nmol/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.57

1.49

1.1

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.45

1.48

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.22

1.44

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

186

1.54

1.44

1.1

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.05

1.44

2.3

1.3

0.54

0.45

0.15

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

127

1.65

1.41

1.0

1.1

39.41

107.19

u/l

0.66

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.75

1.40

2.2

2.0

1.60

2.15

mg/l

0.89

(3010421) pH of Blood

729

6424

1.09

1.39

5.2

4.0

7.42

1.26

640

5879

(3042010) Triglyceride [Moles/volume] in Pleural fluid

371

1.36

1.38

1.5

1.2

0.32

1.51

mmol/l

3.88

238

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

105

808

1.24

1.37

2.7

3.0

29.32

28.47

umol/l

0.37

621

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.20

1.37

1.0

—

(3016879) Cocaine [Presence] in Urine

355

3023

1.12

1.36

1.8

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.60

1.35

1.2

1.0

—

(3022475) Manganese [Moles/volume] in Blood

114

1.68

1.35

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.06

1.35

7.4

9.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

414

1.34

1.35

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2653

24353

1.04

1.34

3.8

3.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

144

1.59

1.34

1.8

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

255

2130

1.14

1.33

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

122

1.64

1.32

1.2

0.05

0.07

g/l

0.71

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1104

0.80

1.32

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

215

1.47

1.29

1.2

—

1.00

mmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

294

2487

1.13

1.28

1.8

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

645

1.26

1.27

1.4

1.7

10.31

5.65

ug/l

0.28

434

(3002523) Influenza virus A Ag [Presence] in Specimen

253

2126

1.14

1.23

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

234

1.43

1.21

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

364

1.34

1.21

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

369

3176

1.11

1.21

1.7

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

414

1.31

1.20

7.1

6.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

199

1649

1.15

1.19

1.1

1.0

2.22

3.17

u/ml

0.61

731

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

867

0.79

1.19

1.3

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

157

1.52

1.17

1.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.83

1.17

1.1

0.21

0.69

umol/24h

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.83

1.17

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

408

1.31

1.17

1.2

1.8

1.73

2.47

ug/l

1.74

239

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

142

1594

0.85

1.16

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

374

3230

1.11

1.16

1.7

2.0

—

(3028300) Cannabinoids [Presence] in Urine

377

3258

1.11

1.15

1.7

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

810

0.79

1.15

1.3

1.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.51

1.15

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.51

1.15

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

376

3251

1.11

1.14

1.7

1.9

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

143

1.54

1.13

1.2

1.4

—

19393.00

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

870

0.80

1.12

1.3

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

136

1.54

1.11

1.0

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

869

0.80

1.11

1.3

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

744

1.22

1.11

2.9

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

744

1.22

1.11

2.9

2.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

868

0.80

1.10

1.3

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.64

1.09

1.1

8.76

8.61

mmol/l

0.14

(3047352) Trisomy 18 risk [Likelihood] in Fetus

728

0.79

1.08

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

201

1682

1.14

1.08

1.0

301.78

349.34

ng/l

0.97

139

1164

(3013762) Body weight Measured

1.88

1.08

1.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.16

1.06

1.0

1.1

1714.29

1878.71

titre

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

241

1.39

1.06

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

467

1.27

1.03

1.2

117.70

24.55

mg/l

0.55

346

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

0.40

0.03

u/ml

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.67

1.02

1.1

1.0

0.57

0.21

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

128

1430

0.85

1.02

1.5

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

101

1.61

1.02

1.0

1.2

820.73

3741.70

ng/l

1.95

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

201

1690

1.14

1.02

1.0

725.80

726.47

ng/l

0.01

137

1126

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

169

0.56

1.01

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

201

1694

1.13

0.99

1.0

43.82

43.41

ng/l

0.04

136

1155

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

180

0.58

0.99

1.5

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

938

0.82

0.98

1.4

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

324

2810

1.10

0.97

6.2

9.7

7.63

7.46

mmol/l

0.33

248

2319

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

523

1.24

0.97

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

157

1.46

0.97

1.1

1.0

—

(3019174) dRVVT (LA screen)

157

1.46

0.97

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

1422

0.86

0.97

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

627

1.22

0.96

1.1

—

(3005033) Fetal Nuchal fold Thickness US

725

0.80

0.95

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

585

1.22

0.95

2.0

1.6

—

270.20

iu/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

755

0.81

0.94

1.4

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.75

0.93

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.86

0.91

1.1

1.4

2.53

2.15

mmol/24h

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

342

1.28

0.88

2.5

3.2

47.05

135.27

ng/l

2.48

108

(40768793) Breast Pathology biopsy report

517

4599

1.07

0.88

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

242

0.67

0.87

1.8

2.4

—

(3044009) aPTT.lupus sensitive (LA screen)

153

1.44

0.87

1.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

210

1.36

0.86

1.3

263.20

372.74

mg/24h

—

(3016228) CD19 cells/100 cells in Blood

109

892

1.17

0.85

2.1

2.0

8.43

8.29

0.04

104

866

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

533

1.22

0.84

1.9

1.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

228

1.34

0.83

1.1

1.0

96.24

83.04

ug/l

0.57

168

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

1.49

0.83

1.4

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

171

1.40

0.83

1.3

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

406

1.25

0.82

2.7

658.70

1749.77

u/l

1.35

362

(3022806) Fractional oxyhemoglobin in Capillary blood

310

3223

0.92

0.81

1.9

1.8

88.56

89.39

1.41

305

3174

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.70

0.80

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

140

1.43

0.80

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

101

1.51

0.78

1.1

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.59

0.78

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

165

1.39

0.78

1.2

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.77

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.79

0.77

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

165

1403

1.12

0.76

1.4

1.3

164.81

169.61

pmol/l

0.18

165

1403

(3015350) Toxocara sp Ab [Presence] in Serum

2.17

0.76

1.0

—

(3019977) pH of Arterial blood

165

1404

1.12

0.76

3.0

2.5

7.41

7.42

1.37

514

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

504

0.80

0.76

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

167

1.37

0.74

1.3

1.5

23.44

41.40

1.59

104

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.65

0.74

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

157

1335

1.12

0.74

1.0

0.26

0.42

u/ml

0.34

368

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

144

1.39

0.71

1.1

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

115

962

1.14

0.70

1.2

66.17

58.29

0.34

104

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

151

0.63

0.70

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

228

1.30

0.68

1.1

2.14

1.74

umol/24h

1.71

228

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

122

1029

1.13

0.67

5.5

4.9

67.25

5067.30

u/ml

0.69

163

(21494814) CD8 cells/100 lymphocytes in Specimen

104

869

1.14

0.66

2.1

1.9

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.77

0.65

1.0

0.10

0.06

u/ml

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

489

1.19

0.65

1.5

1.2

1.40

1.64

mmol/l

0.91

299

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

215

0.71

0.65

1.3

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

147

1.36

0.64

1.3

1.5

16.80

13.47

0.21

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

332

0.78

0.62

1.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

624

5665

1.05

0.62

5.5

4.0

8.35

8.50

kpa

1.25

606

5532

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

292

1.24

0.61

1.4

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

100

1.43

0.60

1.2

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.2

—

468.00

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.59

0.0

1.6

—

16.81

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.58

0.0

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

668

6095

1.05

0.57

1.7

4.10

3.86

mg/l

0.19

537

4518

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

126

1.36

0.56

1.2

1.4

1.08

1.85

0.30

(3018834) Bilirubin.total [Presence] in Urine by Test strip

102

1.40

0.55

2.3

3.9

—

0.00

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

623

1.15

0.55

1.1

1.0

0.49

0.70

u/ml

0.18

166

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.44

0.54

1.0

0.05

0.72

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

220

1.26

0.54

6.3

5.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

111

1.38

0.53

1.1

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.55

0.53

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

221

1.25

0.52

3.0

2.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

413

1.18

0.52

2.3

3.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.62

0.52

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.45

0.52

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.61

0.52

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.51

0.52

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

395

3567

1.06

0.52

3.0

3.6

34.66

40.95

u/ml

0.25

384

3455

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.41

0.51

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

150

0.70

0.51

1.0

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.47

0.50

1.0

1.4

20.50

41.52

e6/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

266

1.22

0.50

1.4

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

194

2000

0.93

0.49

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

609

5571

1.04

0.49

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

267

1.22

0.48

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

267

1.22

0.48

1.4

1.2

—

(40758292) HTLV I+II Ab panel - Serum

329

0.81

0.48

1.5

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

181

1.27

0.48

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

106

1.35

0.46

1.2

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

337

0.82

0.45

1.4

1.6

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

157

1.28

0.45

2.9

2.8

8.72

56.91

pmol/l

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.39

0.44

1.1

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.45

0.43

1.0

0.13

2.38

u/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

458

1.15

0.42

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

731

0.89

0.42

1.8

1.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

613

5638

1.04

0.41

5.4

4.0

5.04

4.99

kpa

0.79

595

5506

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.36

0.41

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.49

0.41

1.0

1.1

—

(3008607) Semen analysis panel

1.49

0.41

1.2

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.35

0.40

1.0

0.03

0.02

u/ml

—

(3003577) Lead [Moles/volume] in Blood

126

1.29

0.40

1.1

1.3

0.12

0.14

umol/l

—

(3012501) Base excess in Blood by calculation

612

5637

1.04

0.39

5.4

4.0

2.74

2.57

mmol/l

0.80

435

3905

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

615

0.88

0.39

1.1

—

(36303858) Crystals [Presence] in Urine

1.36

0.37

1.6

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

215

1.20

0.36

1.1

11.82

19.38

iu/ml

0.57

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.32

0.36

1.0

0.03

0.16

u/ml

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.40

0.35

1.2

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.40

0.35

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

422

1.13

0.34

1.6

1.3

263.44

160.32

titre

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

524

1.11

0.32

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

643

1.10

0.32

1.1

1.2

16.57

26.35

0.62

100

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

555

0.89

0.32

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

210

1.18

0.31

1.0

1.1

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.34

0.31

2.0

2.4

0.08

0.11

ug/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

114

1.26

0.30

1.1

1.4

0.80

1.15

u/field

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

774

1.09

0.30

1.1

99.87

97.64

0.27

598

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

265

1.15

0.29

6.5

7.9

0.30

0.42

umol/l

0.57

237

(3029396) Erythrocyte agglutination [Presence] in Blood

141

1.22

0.29

2.1

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

401

1.12

0.29

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

943

1.07

0.28

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.30

0.28

27.2

11.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

131

1175

1.06

0.28

1.6

1.4

4.69

3.93

0.25

248

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.23

0.27

1.3

1.1

—

mmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

188

1708

1.05

0.26

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

143

0.80

0.26

2.7

3.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

232

1.15

0.26

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

576

5354

1.03

0.25

2.8

2.6

15.66

16.21

2.57

338

2771

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

142

0.81

0.25

5.3

6.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

164

1646

0.95

0.25

1.0

—

(40758358) Immune stain study

100

1.24

0.25

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

406

1.11

0.24

1.2

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

189

1.16

0.24

1.4

2.3

0.63

0.88

mmol/l

0.46

117

(3025549) Creatine [Moles/time] in 24 hour Urine

207

1.15

0.24

1.6

1.4

—

14.60

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

380

1.11

0.23

1.1

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

101

1.23

0.23

1.0

0.01

0.16

u/ml

—

(3001729) Color of Synovial fluid

199

1.15

0.23

1.4

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

110

1.21

0.23

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

149

0.83

0.21

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(3020650) Glucose [Presence] in Urine

494

1.08

0.20

1.4

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.22

0.20

1.0

1.1

4.17

2.36

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

284

1.11

0.19

2.5

1.5

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.24

0.19

1.4

1.1

0.08

0.05

mg/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

358

1.09

0.19

1.4

9.52

8.97

mmol/l

0.57

338

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.21

0.18

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

290

2691

1.03

0.17

1.7

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

410

4003

0.98

0.17

2.0

1.9

1.76

1.73

mmol/l

0.26

400

3903

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.17

0.16

1.1

—

(40763590) HLA-DQ beta [Type]

1.16

0.16

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.14

0.16

1.0

—

(40760409) HLA-A [Type] by High resolution

1.14

0.16

1.0

—

(40760410) HLA-B [Type] by High resolution

1.14

0.16

1.0

—

(3012565) Volume of 24 hour Urine

122

1214

0.96

0.16

2.4

2.2

1865.83

1921.43

0.19

113

1052

(3013862) HLA-DP [Type]

1.11

0.16

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

628

0.94

0.15

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

264

1.08

0.13

2.7

3.1

1.06

1.21

mg/l

0.42

197

(3042517) Benzodiazepines panel - Urine

108

1.15

0.12

1.1

2.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

357

0.94

0.11

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

425

1.06

0.11

1.3

1.2

—

(4034850) Laboratory test

785

7413

1.01

0.10

14.3

10.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

1603

1.02

0.10

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

257

0.93

0.10

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.13

0.10

11.5

8.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

831

1.03

0.09

1.1

27.86

11.31

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

568

0.96

0.09

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

568

0.96

0.09

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

568

0.96

0.09

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

568

0.96

0.09

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

465

1.05

0.09

4.5

6.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

447

1.05

0.08

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

372

1.05

0.08

1.1

1.0

5.23

9.71

u/ml

0.86

187

(3027570) Oxalate [Moles/time] in 24 hour Urine

118

0.89

0.08

1.4

1.3

318.55

336.49

umol/24h

0.09

118

(3050129) First trimester maternal screen panel - Serum or Plasma

114

1061

1.03

0.08

1.6

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.14

0.08

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.04

0.08

1.1

1.0

0.19

0.43

u/ml

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

168

1.08

0.07

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

570

5392

1.01

0.07

1.4

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

251

0.95

0.05

1.2

1.1

80.04

63.03

u/ml

0.45

240

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

794

1.02

0.05

1.4

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

121

1136

1.02

0.05

1.3

1.54

1.56

g/l

0.18

121

1136

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

501

0.97

0.04

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

247

1.04

0.04

6.8

9.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

172

1.05

0.03

2.6

2.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

517

0.98

0.03

2.5

2.4

8.08

7.46

mmol/l

0.46

318

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

600

1.02

0.03

2.8

2.4

148.07

147.53

nmol/l

0.01

514

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

117

1.06

0.02

1.5

1.6

21.97

24.01

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

750

7176

1.00

0.02

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

746

1.01

0.01

2.0

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

413

3953

1.00

0.01

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.03

0.00

1.6

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

426

1.01

0.00

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

301

1.01

0.00

1.7

3.3

39.07

40.09

umol/l

0.10

249

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

139

1.03

0.00

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

125

0.99

0.00

1.9

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

146

0.98

0.00

1.1

2.1

—

(40768795) Lymph node Pathology biopsy report

241

2300

1.00

0.00

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

1295

1.00

0.00

4.1

3.7

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.92

-0.00

1.0

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.99

-0.00

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.00

-0.00

1.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.97

-0.00

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.01

-0.00

1.0

1.1

2.29

1.31

u/field

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

13.88

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.92

-0.00

1.0

1.3

1.27

1.31

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.94

-0.00

1.0

—

12217.43

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.273 [1.17, 1.38]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 11356 out of 53486 females with CD2_BENIGN_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.341 [1.22, 1.47]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 16065 out of 54524 males with CD2_BENIGN_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_COLON.

N-year risk	Females	Males
1	0.097%	0.274%
5	0.585%	1.585%
10	1.462%	3.781%
15	2.948%	7.304%
20	5.116%	12.564%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLON – Benign neoplasm: Colon

GWS hits: 30

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints